| Impurity name | CAS No. | Details |
|---|---|---|
| Atazanavir Sulfate | 229975-97-7 | |
| Atazanavir EP Impurity A | 4385-62-0 | |
| Atazanavir EP Impurity B | 127406-56-8 | |
| Atazanavir EP Impurity C | 1192224-24-0 | |
| Atazanavir EP Impurity D | Not available | |
| Atazanavir EP Impurity E | 1292296-09-3 | |
| Atazanavir EP Impurity F | 1332981-14-2 | |
| Atazanavir EP Impurity G | 1332981-16-4 | |
| Atazanavir EP Impurity H | Not available | |
| Atazanavir EP Impurity I | Not available | |
| Atazanavir EP Impurity J | 198904-86-8 | |
| Atazanavir EP Impurity K | 162537-11-3 | |
| Atazanavir R,S,S,R-Diastereomer | 1292296-11-7 | |
| Atazanavir S,S,R,S-Diastereomer | 1292296-10-6 | |
| Atazanavir enantiomer | Not available | |
| Atorvastatin calcium trihydrate | 344423-98-9 | |
| Atorvastatin calcium | 134523-03-8 | |
| Atorvastatin hemicalcium salt sesquihydrate | 344423-98-9 | |
| Atorvastatin USP Related Compound A | 433289-83-9 | |
| Atorvastatin USP Related Compound B | 887196-25-0 | |
| Atorvastatin USP Related Compound C | 693793-53-2 | |
| Atorvastatin USP Related Compound D | 148146-51-4 | |
| Atorvastatin USP Related Compound E | 1105067-88-6 | |
| Atorvastatin USP Related Compound H | 125995-03-1 | |
| Atorvastatin USP Related Compound >I | 125971-95-1 | |
| Atorvastatin impurity E | 501121-34-2 | |
| Brivaracetam (αS, 4S) isomer | 357336-19-7 | |
| Brivaracetam (αR, 4R) isomer | 357337-00-9 | |
| Brivaracetam (αR, 4S) isomer | 357336-99-3 | |
| Brivaracetam acid impurity | 943986-67-2 | |
| Citalopram Hydrobromide | 59729-32-7 | |
| Escitalopram oxalate | 219861-08-2 | |
| Citalopram EP Impurity A (USP Related Compound A) | 64372-56-1 | |
| Citalopram EP Impurity B (USP Related Compound B) | 411221-53-9 | |
| Citalopram EP Impurity C (USP Related Compound C) | 372941-54-3 | |
| Citalopram EP Impurity D (USP Related Compound D) | 97743-99-2 | |
| Citalopram EP Impurity E | 1332724-08-9 | |
| Citalopram EP Impurity F (USP Related Compound H) | 64372-43-6 | |
| Citalopram EP Impurity G (USP Citalopram Ketone ) | 1329745-98-3 | |
| Citalopram EP Impurity H (USP Related Compound E) | 63284-72-0 | |
| Citalopram Open ring Impurity of USP (Citalopram dehydro of diol) | 920282-75-3 | |
| Desfluoro Citalopram | 1093072-86-6 | |
| R -Citalopram Enantiomer | 219861-53-7 | |
| Chloro Methyl Citalopram | Not available | |
| Clobazam EP Impurity A | 22316-55-8 | |
| Clobazam EP Impurity B | 22316-24-1 | |
| Clobazam EP Impurity C | 22316-16-1 | |
| Clobazam EP Impurity D | 2092997-47-0 | |
| Clobazam EP Impurity E | 75524-13-9 | |
| Clobazam EP Impurity F | 2089061-92-5 | |
| N-desmethylclobazam | 22316-55-8 | |
| Clopidogrel Bisulfate | 120202-66-6 | |
| Clopidogrel Bisulphate EP Impurity C | 135046-48-9 | |
| Clopidogrel Bisulphate EP Impurity A (USP Related Compound A) | 144750-42-5 | |
| (S) + Clopidogrel acid (EP Impurity A) | 144457-28-3 | |
| Clopidogrel Enantiomer (Clopidogrel RC-C) | 120202-71-3 | |
| Clopidogrel Bisulphate EP Impurity B | 144750-52-7 | |
| Clopidogrel Bisulphate Enantiomer (EP Impurity E) | 90055-68-8 | |
| Dapagliflogin | 461432-26-8 | |
| Dapagliflozin propanediol hydrate | 960404-48-2 | |
| Dapagliflozin anomer impurity | 1373321-04-0 | |
| Dapagliflozin Open Ring Impurity | 2100872-88-4 | |
| Methoxy Dapagliflogin | 714269-57-5 | |
| Dapagliflozin Hydroxy Impurity | 960404-86-8 | |
| 4-Bromo-1-chloro-2-(4-ethoxybenzyl)benzene | 461432-23-5 | |
| Dapagliflozin Dimer | 2452300-79-5 | |
| Divalproex Sodium | 76584-70-8 | |
| Doxycycline monohydrate | 17086-28-1 | |
| Doxycyline Hyclate | 24390-14-5 | |
| Doxycycline EP impurity A | 41411-66-9 | |
Doxycycline EP impurity B |
3963-95-9 | |
Doxycycline EP impurity C |
6543-77-7 | |
Doxycycline EP impurity D |
97583-08-9 | |
Doxycycline EP impurity E |
79-57-2 | |
Doxycycline EP impurity F |
122861-53-4 | |
Droxidopa |
23651-95-8 | |
2-(3,4-dihydroxyphenyl)-2-hydroxy-acetaldehyde |
13023-73-9 | |
Droxidopa enantiomer |
51829-99-3 | |
(βR)-β-Hydroxy-3-(phenylmethoxy)-N-[(phenylmethoxy)carbonyl]-O-(phenylmethyl)-L-tyrosine |
55382-14-4 |
|
(2S,3R)-2-Amino-3-(3,4-bis(benzyloxy)phenyl)-3-hydroxypropanoic acid |
106887-48-3 |
|
Erythro Droxidopa |
34047-62-6 | |
| Ezetimibe | 163222-33-1 | |
| Ezetimibe M-Fluoro aniline Analog | 1700622-06-5 | |
| Ezetimibe O-Fluorobenzene Isomer | 1798008-25-9 | |
| (3S)(3S,3R) Ezetimibe Diastereomer | 1593543-00-0 | |
| (3R)(3S,3R) Ezetimibe Enantiomer | 1376614-99-1 | |
| (3R)(3R,3S) Ezetimibe Diastereomer | 163380-16-3 | |
| (3S)(3R,3R) Ezetimibe Diastereomer | 1478664-02-6 | |
| (3'S,3R,4S)-Desfluoro Ezetimibe | 190595-66-5 | |
| Ezetimibe Desfluoroaniline Analog | 302781-98-2 | |
| Ezetimibe Tetrahydro pyran analog | 1296129-15-1 | |
| Ezetimibe Pyran Impurity (Ezetimibe cyclic ether) | 1050631-82-7 | |
| 1,3 Didesfluoro phenyl Ezetimibe | 1251741-03-3 | |
| 3 Desfluoro phenyl Ezetimibe (Ezetimibe desfluoro A) | 190595-66-5 | |
| Felbamate | 25451-15-4 | |
| p-Hydroxyfelbamate | 109482-28-2 | |
| 2-Hydroxyfelbamate | 109482-32-8 | |
| Felbamate Dimer Impurity | 1796927-91-7 | |
| N-Aminocaronyl Felbamate (Allophanate) | 1797130-34-7 | |
| Felbamate Methyl Impurity | 22131-25-5 | |
| Felbamate Ethyl Impurity | 53054-24-3 | |
| Itraconazole | 84625-61-6 | |
| Itraconazole EP Impurity A | 252964-68-4 | |
| Itraconazole EP Impurity B | 854372-77-3 | |
| Itraconazole EP Impurity C | 74855-91-7 | |
| Itraconazole EP Impurity D | 89848-49-7 | |
| Itraconazole EP Impurity E | 252964-65-1 | |
| Itraconazole EP Impurity F | 89848-51-1 | |
| Itraconazole nitro intermediate | 1437468-92-2 | |
| Itraconazole desaklyl | 89848-41-9 | |
| Itraconazole amine intermediate | 1437468-62-6 | |
| Lansoprazole | 103577-45-3 | |
| Lansoprazole sulfone EP Impurity B (USP related copmound A) |
131926-99-3 | |
| Lansoprazole N Oxide; EP Impurity A | 213476-12-1 | |
| Dexlansoprazole | 138530-94-6 | |
| (S)-Lansoprazole | 138530-95-7 | |
| Linezolid | 165800-03-3 | |
| R-Linezolid | 872992-20-6 | |
| Desfluoro Linezolid | 556801-15-1 | |
| Linezolid dimer | 908143-04-4 | |
| Linezolid-N-Oxide | 189038-36-6 | |
| Linezolid USP Related Compound A | 168828-84-0 | |
Linezolid USP Related Compound B |
216868-57-4 | |
Linezolid USP Related Compound C |
168828-90-8 | |
Linezolid USP Related Compound D |
174649-09-3 | |
| Lopinavir | 192725-17-0 | |
| Lopinavir EP impurity A | 192726-05-9 | |
| Lopinavir EP impurity B | Not available | |
| Lopinavir EP impurity C | Not available | |
| Lopinavir EP impurity D | Not available | |
| Lopinavir EP impurity E | 192725-49-8 | |
| Lopinavir EP impurity F | Not available | |
| Lopinavir EP impurity G | Not available | |
| Lopinavir EP impurity H | Not available | |
| Lopinavir EP impurity I | Not available | |
| Lopinavir EP impurity J | Not available | |
| Lopinavir EP impurity K | 1623021-24-8 | |
Lopinavir EP impurity L |
Not available | |
Lopinavir EP impurity M |
Not available | |
Lopinavir EP impurity N |
1798014-18-2 | |
Lopinavir EP impurity O |
Not available | |
Lopinavir EP impurity P |
1217628-64-2 | |
Lopinavir EP impurity Q |
667904-94-1 | |
Lopinavir EP impurity R |
943250-66-6 | |
Lopinavir EP impurity S |
943250-65-5 | |
Lopinavir EP impurity T |
1797024-56-6 | |
| Macitentan Dimer | 2089065-77-8 | |
| N-Despropyl Macitentan | 1103522-45-7 | |
| Macitentan hydroxyl impurity | 1393813-43-8 | |
| Metaxalone | 1665-48-1 | |
| Metaxalone USP related compound A | 2514685-36-8 | |
| Metaxalone USP related compound B | 66766-07-2 | |
| Metaxalone USP related compound C | 805972-34-3 | |
| Metaxalone Impurity: 3,5-Dimethylphenol | 108-68-9 | |
| Metaxalone Impurity: 3-(3,5-Dimethylphenoxy)propane-1,2-diol | 59365-66-1 | |
| Metaxalone Impurity: N-Benzyl Metaxalone | 2385457-74-7 | |
| Metaxalone Impurity: Bis[2-Hydroxy-3-(3,5-dimethylphenoxy)propyl]amine | 805972-34-3 | |
| Metaxalone Impurity: 1-[3-(3,5-Dimethylphenoxy)-2-hydroxypropyl]-3,5-Diglycidyl Isocyanurate | 1392430-16-8 | |
| Metaxalone Impurity: 1,3-Bis-[3-(3,5-Dimethylphenoxy)-2-hydroxypropyl]-5-glycidyl Isocyanurate | 1392430-17-9 | |
| Metaxalone Impurity: 2-[(3,5-Dimethylphenoxy)methyl]oxirane | 4287-30-3 | |
| Milnacipran EP impurity A | 153275-06-0 | |
| Milnacipran EP impurity B | 85-41-6 | |
| Milnacipran EP impurity C | 70209-83-5 | |
| Milnacipran EP impurity D | 60788-55-8 | |
| Milnacipran EP impurity E | 140-29-4 | |
| Milnacipran EP impurity F | 63106-93-4 | |
| Milnacipran EP impurity G | 1353644-49-1 | |
| Milnacipran EP impurity H | 1575528-93-6 | |
| Milnacipran EP impurity I | 1575528-97-0 | |
| Milnacipran EP impurity J | 1100753-09-0 | |
| Milnacipran EP impurity K | 1575529-05-3 | |
| Milnacipran EP impurity L | 153275-06-0 | |
| Milnacipran EP impurity M | 871100-19-5 | |
| Levomilnacipran Hydrochloride | 175131-60-9 | |
| Dextro-Milnacipran | 96847-55-1 | |
| Rifaximin | 80621-81-4 | |
| Montelukast Racemate | Not available | |
| Montelukast Methyl ketone | 184764-13-4 | |
| Montelukast EP impurity-A | 190078-45-6 | |
| Montelukast EP impurity-B | 918972-54-0 | |
| Montelukast EP impurity-F | 937275-23-5 | |
| Montelukast EP impurity-G | 774538-96-4 | |
| Montelukast EP impurity-H | 851755-56-1 | |
| Omeprazole Magnesium | 95382-33-5 | |
| Esomeprazole magnesium trihydrate | 217087-09-7 | |
| Esomeprazole magnesium hydrate | 668985-31-7 | |
| Omeprazole USP Related compound A | 88546-55-8 | |
| Omeprazole USP Related compound B | 37052-78-1 | |
| Omeprazole Related Compound E | 176219-04-8 | |
| Omeprazole Related Compound I | 158812-85-2 | |
| Omeprazole EP Impurity G&F | Not available | |
| Omeprazole EP Impurity B | 110374-16-8 | |
| Omeprazole EP Impurity C | 73590-85-9 | |
| Omeprazole EP Impurity D | 88546-55-8 | |
| Omeprazole EP Impurity H | 863029-89-4 | |
| Omeprazole N-Oxide (EP Impurity E) | 176219-04-8 | |
| Omeprazole R Isomer | 161796-77-6 | |
| N-methyl omeprazole | 89352-76-1 | |
| Paliperidone | 144598-75-4 | |
| Paliperidone hydroxy benzoyl analog | 152542-03-5 | |
| Paliperidone ketone | 1189516-65-1 | |
| Paliperidone N-Oxide | 761460-08-6 | |
| Paliperidone USP Related Compound A | 849903-79-3 | |
| Paliperidone USP Related Compound B | 84163-13-3 | |
| Paliperidone USP Related Compound C | 130049-82-0 | |
| Paliperidone USP Related Compound D | 761460-08-6 | |
| Paliperidone E Oxime | 1388021-46-2 | |
| Paliperidone Z Oxime | 1388021-47-3 | |
| 2-Desmethyl Paliperidone | 1268058-08-7 | |
| Pantoprazole sodium | 164579-32-2 | |
| Pantoprazole USP Related compound A / EP Impurity A | 127780-16-9 | |
| Pantoprazole USP Related compound B / EP Impurity B | 102625-64-9 | |
| Pantoprazole USP Related compound C / EP Impurity C | 97963-62-7 | |
| Pantoprazole USP Related Compounds D and F Mixture | Not available | |
| Pantoprazole Related Compound E | 2115779-15-0 | |
| Paroxetine EP impurity F (N-methylparoxetine) | 110429-36-2 | |
| Rabeprazole sodium | 117976-90-6 | |
| Rabeprazole sodium hydrate | 891191-56-3 | |
| Rabeprazole USP related compound A | 1163685-30-0 | |
| Rabeprazole USP related compound B | 924663-38-7 | |
| Rabeprazole USP related compound C | 583-39-1 | |
| Rabeprazole USP related compound D | 117976-47-3 | |
| Rabeprazole USP related compound E | 117977-21-6 | |
| Rabeprazole USP related compound F | 168167-42-8 | |
| Raloxifene Hydrochloride | 82640-04-8 | |
| Raloxifene N-oxide [EP impurity C] | 195454-31-0 | |
| Raloxifene dimesylate | 84449-85-4 | |
| Raloxifene bismethyl ether | 84541-38-8 | |
| Raloxifene EP impurity A | 1159977-58-8 | |
| Ritonavir | 155213-67-5 | |
| Ritonavir EP Impurity A | 154212-61-0 | |
| Ritonavir EP Impurity B | 765875-58-9 | |
| Ritonavir EP Impurity C | 1010808-43-1 | |
| Ritonavir EP Impurity D | 144142-33-6 | |
| Ritonavir EP Impurity E | 176655-56-4 | |
| Ritonavir EP Impurity F | 1010809-61-6 | |
| Ritonavir EP Impurity G | 2034136-66-6 | |
| Ritonavir EP Impurity H | 1010809-43-4 | |
| Ritonavir EP Impurity I | 165315-26-4 | |
| Ritonavir EP Impurity J | 162849-95-8 | |
| Ritonavir EP Impurity K | 1010809-39-8 | |
| Ritonavir EP Impurity L | 256328-82-2 | |
| Ritonavir EP Impurity M | Not available | |
| Ritonavir EP Impurity N | 202816-62-4 | |
| Ritonavir EP Impurity O | 1414933-81-5 | |
| Ritonavir EP Impurity P | Not available | |
| Ritonavir EP Impurity Q | 155213-67-5 | |
| Ritonavir EP Impurity R | 1414933-80-4 | |
| Ritonavir EP Impurity S | 2084828-53-3 | |
| Ritonavir EP Impurity T | 869368-48-9 | |
| Ritonavir leucine Analog | Not available | |
| Ritonavir Isoleucine Analog | Not available | |
| Sertraline Hydrochloride | 79559-97-0 | |
| Sertraline Trans (1RS,4SR) Isomer (EP Impurity A) | 79836-45-6 (base) ; 329009-20-3, 79617-99-5 (HCl salt) | |
| 3,4 Deschloro sertraline (EP Impurity B) | 62137-24-0 (free base) 52758-05-1 (HCl salt) |
|
| 4 Deschloro sertraline (EP Impurity D) | 2378750-29-7 | |
| Sertraline Enantiomer | 79645-15-1 | |
| (1RS,4SR)-4-(4-Chlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine | 107538-97-6 | |
| Sertraline EP Impurity C HCl (1S,4S-Isomer) | 79646-00-7 | |
| 4-(3,4-Dichlorophenyl)-3,4-dihydronaphthalen-2(1H)-one | 944054-44-8 | |
| Des-methylsertraline HCl | 675126-10-0 | |
| rac-Sertraline EP Impurity F | 79560-19-3 | |
| N-Nitroso-Sertraline | Not available | |
| Ticagrelor | 274693-27-5 | |
| Ticagrelor EP impurity A | 1251765-07-7 | |
| Ticagrelor EP impurity B | 2216753-87-4 | |
| Ticagrelor EP impurity C | 1616703-93-5 | |
| Ticagrelor EP impurity E | 376608-71-8 | |
| Ticagrelor des-hydroxyethyl impurity | 220347-05-7 | View Details |
| 2-(Propylthio)pyrimidine-4,6-diol | 145783-12-6 | |
| 5-Amino-4,6-dichloro-2-(propylthio)pyrimidine | 145783-15-9 | |
| 4,6-Dichloro-5-nitro-2-(propylthio)pyrimidine | 145783-14-8 | |
| (3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-ol | 155899-66-4 | |
| 5-amino-6-chloro-2-(propylthio)pyrimidin-4-ol | Not available | |
| Benzyl (3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyl-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ylcarbamate | 274693-54-8 | |
| Ethyl 2-((3aR,4S,6R,6aS)-6-(benzyloxycarbonyl)-2,2-dimethyl-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)acetate | 866551-95-3 | |
| Ethyl 2-[[(3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]acetate oxalate | 1402149-98-7 (Oxalate); 1265919-24-1 (Base) | |
| Ticagrelor IP Impurity B | 1788033-05-5 | |
| (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine Hydrochloride | 1402222-66-5 | |
| (1S,2R)-2-(3,4-Difluorophenyl)-cyclopropanamine | 1345413-20-8 | |
| rac-(1R,2S)-2-(2,3-Difluorophenyl)cyclopropan-1-amine hydrochloride | 1807939-83-8 | |
| 2-(3-Fluorophenyl)cyclopropanamine hydrochloride | 1157139-62-2 | |
| 2-(4-Fluorophenyl)cyclopropanamine hydrochloride | 879324-66-0 | |
| (1S,2R)-rel-2-(4-chloro-3-fluorophenyl)cyclopropan-1-amine hydrochloride | 1807938-62-0 | |
| Ticagrelor pyrimidine dimer | Not available | |
| Ticagrelor diastereomer-1 | 2096989-56-7 | |
| Ticagrelor enantiomer impurity | 2096989-55-6 | |
| Ticagrelor Acetonide | 274693-26-4 | |
| 2-(((3aR,4S,6R,6aS)-6-((5-Amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol | 376608-74-1 | |
| (1R,2R)-2-(3,4-Difluorophenyl)-cyclopropanecarbonyl Azide | 378236-67-0 | |
| Tolterodine 6-Methyl 4-Phenylchroman-2ol | 209747-04-6 | |
| Valproic acid | 99-66-1 | |
| Valproic acid USP related compound A | 99-67-2 | |
| Valproic Acid USP Related Compound B | 62391-99-5 | |
| Valproic Acid USP Related Compound K | 5343-52-2 | |
| Valproic acid ethyl ester | 17022-31-0 | |
| Valproic acid propyl ester | Not available | |
| Valproic acid methyl ester | 22632-59-3 | |
| 2-Butylvaleric acid | 3274-28-0 | |
| Vortioxetine hydrobromide | 960203-27-4 | |
| N-Nitroso Vortioxetine | 1801352-86-2 | |
| Vortioxetine impurity 1-(2-BROMOPHENYL)PIPERAZINE | 1011-13-8 | |
Ziprasidone hydrochloride monohydrate |
138982-67-9 | |
| Ziprasidone Open ring | 1159977-64-6 | |
| Ziprasidone Piperazine derivative (EP " A") | 87691-87-0 | |
| Ziprasidone EP impurity B | 1159977-56-6 | |
| Deschloro Ziprasidone | 118305-72-9 | |
| Benzisothiazolyl Ziprasidone (EP " E") | 1159977-04-4 | |
| 2-(4-Nitroso-1-piperazinyl)benzothiazole | 37015-96-6 | |
| N-nitrosoziprasidone | Not available | |
| Abiraterone acetate | 154229-18-2 | |
| Anhydro Abiraterone | 154229-20-6 | |
| Abiraterone Isopropyl ether | 165334-68-9 | |
| O-Chloro Butyl Abiraterone | 2484719-17-5 | |
| Abiraterone Ethyl ether | 2484719-14-2 | |
| 5,6-Dihydroabiraterone | 219843-75-1 | |
| Abiraterone propionate | 1620323-43-4 | |
| N-methyl-N-nitroso-2-Propanamine | 30533-08-5 | |
| Nitroso Sitagliptin -1 | 1481965-39-2 | |
| 2-({4-[(7- chloroquinolin-4-yl)-(2-{[4-(7-chloro quinolin-4-yl amino)-plutyl]-ethyl amino}-ethyl)-amino]-pantyl}-ethylamino)-ethanol | 2732209-42-4 | |
| (4RS)-4-[(7-Chloroquinolin-4-yl)amino]pentan-1-ol Hydrochloride | 10500-64-8 | |
| 7-Chloro-4-(2-methyl-1-pyrrolidinyl)-quinoline | 6281-58-9 | |
| N4-(7-Chloro-4-quinolinyl)-N1-ethyl-1, 4-pentanediamine hydrochloride | 4298-11-7 | |
| 4-[(7-chloroquinolin-4-yl)amino]-N-ethyl-N-(2-hydroxyethyl)pentan-1-amine oxide | 1449223-88-4 | |
| Ruxolitinib Phosphate Impurity B | Not available | |
| tert-Butyl ((trans-4-cyanocyclohexyl)methyl)carbamate | 473923-79-4 | |
| 4-Hydroxycyclohexanecarbonitrile | 24056-34-6 | |
| trans-1-(Boc-amino)-4-cyanocyclohexane | 873537-32-7 | |
| 6-O-Beta-D-galactopyranosyl-D-galactose | 5077-31-6 | |
| 2-(hydroxymethyl)-2-nitropropane-1,3-diol | 126-11-4 | |
| Mafenide impurity-C | 771581-28-3 | |
| 5-Phenoxyindan-1-one | 142369-18-4 | |
| 4-Phenoxyphthalonitrile | 38791-62-7 | |
| 4-Phenoxyphthalic acid | 37951-15-8 | |
| 5-Phenoxyisobenzofuran-1,3-dione | 21345-01-7 | |
| D-Phenylglycinol | 56613-80-0 | |
| 3-Chlorobenzo[d]isothiazole | 7716-66-7 | |
| (1R,2R)-Cyclohexane-1,2-diyldimethanol | 65376-05-8 | |
| 3-(1-Piperazinyl)-1,2-benzisothiazole | 87691-87-0 | |
| (3aR,7aR)-4'-(1,2-Benzisothiazol-3-yl)octahydrospiro[2H-isoindole-2,1'-piperazinium] methanesulfonate | 186204-37-5 | |
| 3-(4-(Methylsulfonyl) piperazin-1-yl)benzo[d] isothiazole | 2190680-18-1 | |
| (3aR,3a′R,4S,4′S,7R,7aS,7′R, 7a′S)-2,2′-(((1R,2R)- cyclohexane-1,2-diyl)bis(methylene))bis(hexahydro-1H-4, 7-methanoisoindole-1,3(2H)-dione) | 1932329-76-4 | |
| exo-Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione | 14805-29-9 | |
| Benzisothiazolone | 2634-33-5 | |
| (1R,2R)-(-)-1,2- |
46022-05-3 | |
| (1S,2S)-Cyclohexane-1,2-dicarboxylic acid | 21963-41-7 | |
| cis-Cyclohexane-1,2-dicarboxylic acid | 610-09-3 | |
| Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione | 6713-41-3 | |
| hexahydro-4,7-methanoisobenzofuran-1,3-dione | 6004-79-1 | |
| (1R,2R)-1,2-Cyclohexanedimethanol 1,2-Dimethanesulfonate | 186204-35-3 | |
| Lurasidone enantiomer | 1448443-35-3 | |
| 1-(Difluoromethyl)-4-nitrobenzene | 29848-57-5 | |
| 4-Oxoadamantane-1-carboxylic acid | 56674-87-4 | |
| Dabigatran impurity | 2733025-09-5 | |
| 5-Bromo-2-adamantanone | 20098-20-8 | |
| 3-Desacetyl Cefotaxime Lactone | 66340-33-8 | |
| 7-Aminocephalosporanic acid | 957-68-6 | |
| Tetrahydro-2-methyl-3-thioxo-1,2,4-triazine-5,6-dione | 58909-39-0 | |
| Ceftriaxone Sodium intermediate;AE- active ester;Ceftriaxone impurity D;Cefotaxime Impurity 46;4-thiazolethiolacetate; Ceftriaxone EP Impurity D;S-2-Benzothiazolyl-2-amino-; Ceftriaxone Sodium Ep Impurity D | 80756-85-0 | |
| Ceftriaxone impurity E Ceftriaxone EP Impurity E 7-AMINOCEPHALOSPORANIC TRIAZINE |
58909-56-1 | |
| Ceftriaxone | 73384-59-5 | |
| Ceftriaxone sodium E-isomer | 97164-54-0 | |
| 4-Hydroxy-1-adamantanecarboxylic acid | 81968-77-6 | |
| 5-(Methoxycarbonyl)-2-adamantanone | 56674-88-5 | |
| Methyl 4-(methoxyimino)tricyclo[3.3.1.13,7]decane-1-carboxylate | 2031258-37-2 | |
| Methyl spiro[1,3-dioxolane-2,2′-tricyclo[3.3.1.13,7]decane]-5′-carboxylate | 84454-62-6 | |
| Spiro[1,3-dioxolane-2,2′-tricyclo[3.3.1.13,7]decane]-5′-methanol | 110852-41-0 | |
| Spiro[1,3-dioxolane-2,2′-tricyclo[3.3.1.13,7]decane]-5′-carboxaldehyde | 2172884-64-7 | |
| (αS)-α-[[(1R)-2-Hydroxy-1-phenylethyl]amino]spiro[1,3-dioxolane-2,2′-tricyclo[3.… | 2173146-29-5 | |
| (S)-2-((tert-Butoxycarbonyl)amino)-2-((1s,3R,5S,7R)-4-oxoadamantan-1-yl)acetic Acid | 2173146-31-9 | |
| Boc-3-Hydroxy-1-adamantyl-D-glycine | 361442-00-4 | |
| (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester | 361440-67-7 | |
| Methyl trityl ether | 596-31-6 | |
| Tritanol | 76-84-6 | |
| Saxagliptin Cyclic Amidine Impurity | 1350800-76-8 | |
| Saxagliptin | 361442-04-8 | |
| Saxagliptin Cyclic Amide | 1350800-77-9 | |
| (1S,3S,5S)-2-(tert-Butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid | 197142-36-2 | |
| (1S,3S,5S)-2-Azabicyclo-[3.1.0]hexane-3-carboxylic acid | 214193-13-2 | |
| (1S,3S,5S)-2-tert-Butyl 3-ethyl 2-azabicyclo[3.1.0]hexane-2,3-dicarboxylate | 214193-11-0 | |
| tert-Butyl (1R,3S,5R)-3-Carbamoyl-2- |
1445592-86-8 | |
| tert-Butyl ((1S)-2-((1S,3S,5S)-3- |
361442-01-5 | |
| Elagolix N-oxide | 2486454-63-9 | |
| Elagolix Impurity-D | Not available | |
| Desbutyrate elagolix | 830346-50-4 | |
| N-Methyl-3-chloropropylamine Hydrochloride | 97145-88-5 | |
| 4-Isothiocyanato-2-( |
143782-23-4 | |
| Medroxyprogesterone Acetate | 71-58-9 | |
| 3-Oxoatorvastatin | 1391052-00-8 | |
| Eberconazole Keto | 130126-88-4 | |
| Eberconazole hydroxyl | 130126-89-5 | |
| Eberconazole chloro | 130104-38-0 | |
| Eberconazole C-transposition | Not available | |
| MESNA EP impurity C | 69536-71-6 | |
| MESNA EP Impurity D | 45127-11-5 | |
| MESNA | ||
| 2-[[(3aR,4S,6R,6aS)-6-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]ethanol | 376608-75-2 | |
| Metaprolol impurity A (FREE BASE) | 109632-08-8 | |
| Desbromo dapagliflozin | 2444702-80-9 | |
| 4-Deschloro-4-bromo dapagliflozin | 1807632-95-6 | |
| Metformin related compound A | 461-58-5 | |
| Metformin EP Impurity E | 1609-00-3 | |
| Mesalazine EP impurity F | 570-23-0 | |
| Chlorthalidone impurity-J | 956-92-3 | |
| N-[(1 R)-2-[1, 1 '-Biphenyl]-4-yl-1- (hydroxymethyl) ethyl]carbamic acid 1, 1- dimethylethyl ester (Sacubitril Impurity) | 1426129-50-1 | |
| (R)-(-)-4-Benzyl-3-propionyl-2-oxazolidinone | 131685-53-5 | |
| 2,2′-[(3-Chlorophenyl)imino]bis[ethanol] | 92-00-2 | |
| Ethanol, 2,2′-[(3-chlorophenyl)imino]bis-, hydrochloride (1:1) | 63589-35-5 | |
| 3-Chloro-N,N-bis(2-chloroethyl)benzenamine | 5520-28-5 | |
| Benzenamine, 3-chloro-N,N-bis(2-chloroethyl)-, hydrochloride (1:1) | 102837-02-5 | |
| 2-(3-Chloropropyl)-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | 19666-40-1 | |
| 2-(3-Bromopropyl)-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | 1094305-62-0 | |
| 2-(3-Hydroxypropyl)-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | 53689-26-2 | |
| 2-(3-Azidopropyl)-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | 1250938-03-4 | |
| 1H-Isoindole-1,3(2H)-dione, 2-[3-(3-oxo-1,2,4-triazolo[4,3-a]pyridin-2(3H)-yl)propyl]- | 1386675-28-0 | |
| 2-(4-Chlorobutyl)-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | 775325-28-5 | |
| 2-(4-Bromobutyl)-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | 1094459-19-4 | |
| 2-(4-Hydroxybutyl)-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | 1156068-60-8 | |
| 2-(4-Aminobutyl)-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | 1019114-84-1 | |
| 2-(3-Aminopropyl)-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | 1019115-81-1 | |
| 1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one, 2-(3-aminopropyl)-, hydrochloride (1:1) | 1193388-32-7 | |
| 2-[3-[(2-Methoxyethyl)amino]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | 1490887-83-6 | |
| 2-[3-[Bis(2-hydroxyethyl)amino]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | 50594-91-7 | |
| 1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one, 2-[3-[bis(2-hydroxyethyl)amino]propyl]-, hydrochloride (1:1) | 53689-27-3 | |
| 2-[3-(4-Morpholinyl)propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | 801176-50-1 | 2-[3-[Bis(2-chloroethyl)amino]propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | 53689-10-4 |
| 2-(5-Chloropentyl)-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | 1097807-61-8 | |
| 3,5-Pyridinedicarboxylic acid | 499-81-0 | |
| 3,5-Pyridinedicarboxylic acid, 3,5-dimethyl ester | 4591-55-3 | |
| 3,5-Pyridinedicarboxylic acid, 3,5-diethyl ester | 4591-56-4 | |
| 3,5-Pyridinedicarboxylic acid, 3,5-diethyl ester, hydrochloride | 121177-06-8 | |
| 3,5-Pyridinedimethanol | 21636-51-1 | |
N-alkylated ranolazine |
1983943-76-5 | |
| Vildagliptin dipyrrolidine impurity | 6708-06-1 | |
Montelukast sulfone |
1266620-74-9 | |
| Quetiapine N-oxide (EP Impurity H) | 1076199-40-0 | |
| Methoxy Tamsulosin (EP "D") | 80223-96-7 | |
| Tert-butyl (R)-(1-([1,1'-biphenyl]-4-yl)-3- bromopropan-2-yl)carbamate(Sacubitril Impurity) | 1835193-08-2 | |
| Lacosamide Impurity H | 1375090-19-9 | |
| Lacosamide impurity C | 74855-91-7 | |
| Lacosamide Impurity G | 588-46-5 | |
| Lacosamide Impurity I | 2295925-90-3 | |
| Lacosamide Impurity J | 100-46-9 | |
| Lacosamide Impurity F | 171623-02-2 | |
| Lacosamide Impurity D | 196601-69-1 | |
| Lacosamide Impurity K | 86921-49-5 | |
| 3-(4-chlorophenyl)isoindolin-1-one | 2224-77-3 | |
| Milrinone amide impurity | 80047-24-1 | |
| 2-Methyl-2-Thiazoline-4-Carboxylic acid sodium salt | 15058-19-2 | |
| Linagliptin impurity / (R)-7-(but-2-yn-1-y1)-3-methyl-1-((4-inethylquinazolin-2-yl)methyl)-8-{piperidin-3-ylainino)-1H-purine-2,6(3H,7 H)-dione | 1446263-38-2 | |
| Linagliptin impurity / (R,E)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-y1)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1 H-purine-2,6 (3H,7H)-dione | 1446263-39-3 | |
| Linagliptin impurity / 7-(but-2-yn-1-yl)-3-methyl-1((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | 1911621-52-7 | |
| Linagliptin impurity / (R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methy1quinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-IH-purin-8-yl)piperidin-3-yl)acetamide. | 1803079-49-3 | |
| Linagliptin impurity / 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-ntethylquinazolin-2-yl}methyl)-1H-purine-2,6(3H,7H)-dione | 853029-57-9 | |
| Linagliptin impurity / (R)-7-{but-2-yn-1-y1)-8-(3-((7-(but-2-yn-1-yl)-3-methy1-1-((4-methy1quinazolin-2-y1)methy1)-2,6-dioxo-2,3,6,7- tetiahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methy1-1-((4-methy1quinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | 2253964-98-4 | |
| Linagliptin impurity / 8((R)-3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-1((4-(2-(((R)- 1(7-(but-2-yn-1-yl)-3-methyl-1-((4-inethylquinazolin-2- yl) methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8- yl)piperidin-3-yl)amino)ethyl)quinazolin-2-yl)methyl)-3-methyl-3,7-dihydro-1 H-purine-2,6-dione | 141833-47-7 | |
| Linagliptin impurity / (S)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl) methyl)-1H-purine-2,6(3H,7 H)-dione | 2253964-85-9 | |
| Linagliptin impurity / 3-Aminopiperidine | 334618-23-4 | |
| Linagliptin impurity / 2-(Chloomethyl)-4-methyl quinazoline | 109113-72-6 | |
| Linagliptin impurity / (R)-tert--butyl1-(7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-ylcarbamate | 1446263-38-2 | |
| Linagliptin impurity / 8-bromo-3-methyl-3,7-dihydro-1H-purine-2,6-dione | 93703-24-3 | |
| Norepinephrine Impurity B | 5090-29-9 | |
| Norepinephrine Impurity D | 1932110-67-2 | |
| Norepinephrine Bitartrate Isomer (Norepinephrine enantiomer) | 149-95-1 | |
| (Norepinephrine Impurity A) | 51-42-3 | |
| Dopamine hydrochloride(Norepinephrine Impurity C) | 62-31-7 | |
| 2-Chloro-1-(3,4-dihydroxyphenyl)ethanone (Norepinephrine Impurity E) | 99-40-1 | |
| Dibenzylamine (Norepinephrine Impurity F) | 103-49-1 | |
| 2-(Dibenzylamino)-3',4'-dihydroxy-acetophenone (Norepinephrine Impurity G) | 13062-58-3 | |
| Solifenacin Impurity F (RS isomer) | 180468-40-0 | |
| Solifenacin Impurity G (RR isomer) | 740780-79-4 | |
| Solifenacin Impurity H (SS isomer) | 180468-38-6 | |
| 1-[[(2R,3S)-2-(2,4-Difluorophenyl)-3-methyloxiranyl]methyl]-1H-1,2,4-triazole | 127000-90-2 | |
| Aspartame Related Compound A | 5262-10-2 | |
| 8-Chlorotheophylline | 85-18-7 | |
| Famotidine Related Compound F (USP) | 107880-74-0 | |
| Famotidine Related Compound E (USP) | 129083-44-9 | |
| Topiramate EP Impurity-C | 106881-41-8 | |
| Pemafibrate | 848259-27-8 | |
| Pemafibrate butyl ester | 907192-61-4 | |
| Pemafibrate ethyl ester | 916515-12-3 | |
| 2-Benzoxazolethiol | 2382-96-9 | |
| N- (3-bromopropyl)phthalimide | 5460-29-7 | |
| N-[3-(4-methoxy-phenoxy)-propyl]-phthalimide | 100840-46-8 | |
| 3- (4-methoxyphenoxy)propan-1-amine | 100841-00-7 | |
| 3-(((3-(4-Methoxyphenoxy)propyl)amino)methyl)phenol | 907192-58-9 | |
| 3-[[2-Benzoxazolyl[3-(4-methoxyphenoxy)propyl]amino]methyl]phenol | 848260-89-9 | |
| (S)-2-[(Trifluoromethylsulfonyl)oxy]butanoic acid butyl ester | 907192-60-3 | |
| ethyl (S)-2-hydroxybutanoate | 88271-13-0 | |
| tert-Butyl(S)-(-)-2-hydroxybutyrate | 37787-90-9 | |
| 2-Chlorobenzoxazole | 615-18-9 | |
| Pemafibrate methyl analogue | Not available | |
| Atracurium Ph Eur Impurity A / R-cis-PAMQ RS | 1075727-06-8 | |
| Atracurium Ph Eur Impurity B / N-Methyl-laudanosine RS | 2480467-84-1 | |
| Atracurium Ph Eur Impurity C / R-Laudanosine RS | 85-63-2 | |
| Atracurium Ph Eur Impurity D / PMMQ RS | 1075726-88-3 | |
| Atracurium Ph Eur Impurity F / Monoester of cis-ATRC RS | 1100676-16-1 | |
| Atracurium Ph Eur Impurity O / Acrylate of cis-ATRC RS | 155913-31-8 | |
| Atracurium Ph Eur Impurity M / Impurity H2 RS | 1193104-85-6 | |
| Atracurium Ph Eur Impurity K / Impurity I2 RS | Not avaialble | |
| Atracurium Ph Eur Impurity I / Impurity K2 (contains two diastereomers) RS | 1193104-82-3 | |
| Atracurium R,S-ATRC (Diastereomer) | Not avaialble | |
| Cis-Atracurium Ph Eur Impurity W / Monoacetate of cis-ATRC RS | 2411761-86-7 | |
| Atracurium R,R-cis-cis-ATRC RS | 96946-42-8 | |
| Cis-atracurium CIS-ATRC IMPURITY G | Not avaialble | |
| Droxidopa benzyloxy carbamate | 55382-14-4 | |
| Tetrahydrofuran-3-yl toluene-4-sulfonate | 13694-84-3 | |
| (3S)-tetrahydro-3-furanyl 4-methylbenzenesulfonate | 112052-11-6 | |
| (3R)-Tetrahydrofuran-3-yl4-Methylbenzenesulfonate | 219823-47-9 | |
| Febuxostat Amide | 1239233-86-3 | |
| Febuxostat Diacid | 1239233-87-4 | |
| Febuxostat Ethyl Ester | ||
| Methyl 2-(4-(4-(4-(hydroxy diphenylmethyl)piperidin-1-yl)butanoyl)phenyl)-2-methylpropanoate | 154477-55-1 | |
| 3-(3,4-difluorophenyl)acryloyl chloride | 1043546-64-0 | |
| 51336-97-1 | ||
| 1006376-63-1 | ||
| Febuxostat Ethyl Ester | 160844-75-7, | |
| Febuxostat Isopropyl Ester | 1346238-10-5 | |
| Febuxostat Methyl Ester | 923942-34-1 | |
| O-Desisobutyl-O-n-propyl Febuxostat | 1530308-87-2 | |
| Formyl Febuxostat | 144060-62-8 | |
| Sitagliptin S-isomer | 823817-58-9 | |
| Alcohol KSM-01(Tolvaptan Impurity | 1310357-40-4 | |
| Deferasirox Impurity F | 619-67-0 | |
| Isopropyl methanesulfonate | 926-06-7 | |
| Deferasirox Stage-1 Impurity | 1218-69-5 | |
| Deferasirox Methyl ester | 1266741-05-2 | |
| Efinaconazole | 164650-44-6 | |
| 3,5-Bis(chloromethyl)pyridine | 41711-38-0 | |
| 3,5-Bis(chloromethyl)pyridine hydrochloride | 1210824-61-5 | |
| Norfloxacin EP impurity E (RC E) | 75001-78-4 | |
| (R)-N-(3-((3-Fluoro-4-morpholinophenyl)amino)-2-hydroxypropyl)acetamide | 333753-67-6 | |
| 3-Deoxy-3-acetyl abiraterone-3-ene | 2697127-16-3 | |
| Abiraterone acetate N-Oxide. | 2517964-85-9 | |
| Abiraterone acetate5,6-epoxide | 1868064-50-9 | |
| 7-Ketoabiraterone Acetate | 2410075-48-6 | |
| a-Epoxyabiraterone Acetate | 2484719-11-9 | |
| Beta-epoxyabiraterone acetate | 2484719-26-6 | |
| Abiraterone | 154229-19-3 | |
| Abiraterone ethyl ether | 2484719-14-2 | |
| Abiraterone isopropyl ether | 165334-68-9 | |
| Anhydroabiraterone | 154229-20-6 | |
| 3-Deoxy-3-chloroabiraterone | 2484719-16-4 | |
| O-Chlorobutylabiraterone | 2484719-17-5 | |
| Paracetamol impurity k | 123-30-8 | |
| Acetaminophen Related Compound J | 539-03-7 | |
| Paracetamol - Impurity F | 100-02-7 | |
| 2-Bromo-5-iodobenzoic acid | 25252-00-0 | |
| 2-bromobenzoic acid | 88-65-3 | |
| Methyl 2-bromo-5-iodobenzoate | 717880-58-5 | |
| Ethyl 2-bromo-5-iodobenzoate | 1208075-44-8 | |
| 2-(1H-Imidazol-5-yl)acetic acid | 645-65-8 | |
| 2-(1H-Imidazol-5-yl)acetic acid hydrochloride | 3251-69-2 | |
| (S)-3-(4-(2-Chlorobenzyl)phenoxy)tetrahydrofuran | 2517968-35-1 | |
| 1-Chloro-2-[(4-ethoxyphenyl)methyl]benzene | 1662702-90-0 | |
| (S)-3-(4-(2-Chlorobenzoyl)phenoxy)tetrahydrofuran | 2452301-22-1 | |
| (2-Chlorophenyl)(4-hydroxyphenyl)methanone | 55270-71-8 | |
| (1R,2S,3R,4R,5R)-1-(4-Chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)hexane-1,2,3,4,5,6-hexaol| | 1620758-34-0 | |
| Empagliflozin R/S-Furanose | 1620758-32-8 | |
| Empagliflozin α Isomer | 1620758-33-9 | |
| 1-Methoxy Empagliflozin | 1279691-36-9 | |
| Cladribine Regio Isomer [Cladribine Impurity 1] | 172792-37-9 | View Details |
| 7H-Purine, 2,6-dichloro-7-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl] | 91713-50-7 | |
| Hoffer's chlorosugar | 4330-21-6 | |
| 2,6-Dichloropurine | 5451-40-1 | |
| 9H-Purine, 2,6-dichloro-9-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-α-D-erythro-pentofuranosyl] | 38925-00-7 | |
| 4(1H)-Pyridinone, 1-[2-chloro-9-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-α-D-erythro-pentofuranosyl]-9H-purin-6-yl] | 1848981-16-7 | |
| Adenosine, 2-chloro-2′-deoxy-, 3′,5′-diacetate | 146196-13-6 | |
| Cladribine - Impurity A
|
4546-70-7 | |
| Cladribine - Impurity B
|
24757-70-8 | |
| Cladribine - Impurity C
|
1839-18-5 | |
| Cladribine - Impurity E
|
1831121-84-6 | |
| Cladribine - Impurity F
|
619-55-6 | |
| Cladribine - Impurity G
|
99-75-2 | |
| Propyl 4-methylbenzoate
|
9015-73-0 | |
| Cladribine Related Compound A
|
24757-70-8 | |
| 2'-Deoxy-α-Adenosine
|
3413-66-9 | |
| 1-(2,3-DIhydro-1,4-benzodioxin-6-yl)-3-(3-phenyl-1-pyrrolidinyl)-1-propanone hydrochloride | 33025-33-1 | |
| Ethyl 3-({3-amino-4-[(3,5-dimethoxy-2,4,6-triazine)(methyl)amino]benzoyl}pyridin-2-yl-amino)propanoate
(Dabigatran impurity) |
Not available | |
| 2-[(4-cyanophenyl)amino]-N-(4-cyanophenyl)-acetamide | 1900865-84-0
|
|
| Ethyl 3-[(4-{[N-(4-cyanophenyl)glycyl](methyl)amino}3- aminobenzoyl)pyridin-2-ylamino]propanoate
|
1648817-93-9 | |
| Ethyl 2-[(4-carbamimidoyl-phenylamino)-methyl]-1-methyl-1H-benzoimidazole-5-carboxylate
|
1408238-41-4
|
|
| 2-[(4-cyanophenyl)amino]acetic acid
|
42288-26-6 | |
| ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate | 212322-56-0 | |
| Boc-D-His(Trt)-OH | 393568-74-6 | |
| Fmoc-AEEA-OH | 166108-71-0 | |
| Boc-AEEA-OH | 108466-89-3 | |
| H-AEEA-OH | 134978-97-5 | |
| Boc-AEEA-AEEA | 1069067-08-8 | |
| 2-[2-[(Triphenylmethyl)amino]ethoxy]ethanol | 202873-24-3 | |
| Palbociclib Imp-A | 1082876-26-3 | |
| Palbociclib Imp-B | 571189-64-5 | |
| Palbociclib Imp-C | 2624141-94-0 | |
| Palbociclib Imp-D | 775288-71-6 | |
| Palbociclib Imp-E | 851067-56-6(free base) | |
| Palbociclib Imp-G | 1651214-74-2 | |
| Sorafenib Impurity A | 284462-37-9 | |
| Sorafenib Impurity B | 2004659-84-9 | |
| Sorafenib Impurity C | 320-51-4 | |
| Sorafenib Impurity H BP | 1431697-81-2 | |
| 2-aminothiophenol | 137-07-5 | |
| Ondasetron EP Impurity A | 153139-56-1 |
|
| Ondasetron EP Impurity B | 1076198-52-1 | |
| Ondasetron EP Impurity C | 27387-31-1 | |
| Ondasetron EP Impurity D | 99614-64-9 | |
| Ondasetron EP Impurity E | 288-32-4 | |
| Ondasetron 2-Methyl imidazole EP Impurity F | 693-98-1 | |
| Ondasetron EP Impurity G | 99614-03-6 | |
| Ondasetron EP Impurity H | 99614-14-9 | |
| 2-nitro-1,3-propanediol | 1794-90-7 | |
| 2-bromo-2-nitropropane-1,3-diol | 52-51-7 | |
| Tris(hydroxymethyl)nitromethane | 126-11-4 | |
| (S)-5,7-difluorochroman-4-ol | 942195-91-7 | |
| 5,7-Difluoro-3,4-dihydro-2H-1-benzopyran-4-ol | 917248-51-2 | |
| (4R)-5,7-Difluoro-3,4-dihydro-2H-1-benzopyran-4-ol | 1270294-05-7 | |
| R-(-)-2-aminobutanamide hydrochloride (RABAM HCl) | [103765-03-3] | |
| S-2-aminobutyramide hydrochloride (SABAM) | [7682-20-4] | |
| (S)-4-propyldihydrofuran-2(3H)-one | 63095-60-3 | |
| Clemastine Impurity C | 59767-24-7 | |
| Clemastine Impurity D | 67004-64-2 | |
| Clemastine Fumarate | 14976-57-9 | |
| Clemastine Impurity A | 108825-05-4 | |
| Clemastine Impurity B | 1352549-49-5 | |
| Benazepril Impurity B | 88372-39-8 | |
| 5-amino-N-(4-(bis(5-amino-2-methylphenyl)methyl)phenyl)-2-methylbenzenesulfonamide | 1226500-00-0 | |
| Pazopanib trimer | 1226500-01-1 | |
| Norfloxacin EP impurity E (RC E) | 75001-78-4 | |
| (R)-N-(3-((3-Fluoro-4-morpholinophenyl)amino)-2-hydroxypropyl)acetamide | 333753-67-6 | |
| 3-Deoxy-3-acetyl abiraterone-3-ene | 2697127-16-3 | |
| Abiraterone acetate N-Oxide. | 2517964-85-9 | |
| Abiraterone acetate5,6-epoxide | 1868064-50-9 | |
| 7-Ketoabiraterone Acetate | 2410075-48-6 | |
| a-Epoxyabiraterone Acetate | 2484719-11-9 | |
| Beta-epoxyabiraterone acetate | 2484719-26-6 | |
| Abiraterone | 154229-19-3 | |
| Abiraterone ethyl ether | 2484719-14-2 | |
| Abiraterone isopropyl ether | 165334-68-9 | |
| Anhydroabiraterone | 154229-20-6 | |
| 3-Deoxy-3-chloroabiraterone | 2484719-16-4 | |
| O-Chlorobutylabiraterone | 2484719-17-5 | |
| Paracetamol impurity k | 123-30-8 | |
| Acetaminophen Related Compound J | 539-03-7 | |
| Paracetamol - Impurity F | 100-02-7 | |
| 2-Bromo-5-iodobenzoic acid | 25252-00-0 | |
| 2-bromobenzoic acid | 88-65-3 | |
| Methyl 2-bromo-5-iodobenzoate | 717880-58-5 | |
| Ethyl 2-bromo-5-iodobenzoate | 1208075-44-8 | |
| 2-(1H-Imidazol-5-yl)acetic acid | 645-65-8 | |
| 2-(1H-Imidazol-5-yl)acetic acid hydrochloride | 3251-69-2 | |
| (S)-3-(4-(2-Chlorobenzyl)phenoxy)tetrahydrofuran | 2517968-35-1 | |
| 1-Chloro-2-[(4-ethoxyphenyl)methyl]benzene | 1662702-90-0 | |
| (S)-3-(4-(2-Chlorobenzoyl)phenoxy)tetrahydrofuran | 2452301-22-1 | |
| (2-Chlorophenyl)(4-hydroxyphenyl)methanone | 55270-71-8 | |
| (1R,2S,3R,4R,5R)-1-(4-Chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)hexane-1,2,3,4,5,6-hexaol| | 1620758-34-0 | |
| Empagliflozin R/S-Furanose | 1620758-32-8 | |
| Empagliflozin α Isomer | 1620758-33-9 | |
| 1-Methoxy Empagliflozin | 1279691-36-9 | |
| Cladribine EP Impurity D | 5542-92-7 | View Details |
| 7H-Purine, 2,6-dichloro-7-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl] | 91713-50-7 | |
| Hoffer's chlorosugar | 4330-21-6 | |
| 2,6-Dichloropurine | 5451-40-1 | |
| 9H-Purine, 2,6-dichloro-9-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-α-D-erythro-pentofuranosyl] | 38925-00-7 | |
| 4(1H)-Pyridinone, 1-[2-chloro-9-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-α-D-erythro-pentofuranosyl]-9H-purin-6-yl] | 1848981-16-7 | |
| Adenosine, 2-chloro-2′-deoxy-, 3′,5′-diacetate | 146196-13-6 | |
| Cladribine - Impurity A | 4546-70-7 | |
| Cladribine - Impurity B | 24757-70-8 | |
| Cladribine - Impurity C | 1839-18-5 | |
| Cladribine - Impurity E | 1831121-84-6 | |
| Cladribine - Impurity F | 619-55-6 | |
| Cladribine - Impurity G | 99-75-2 | |
| Propyl 4-methylbenzoate | 9015-73-0 | |
| Cladribine Related Compound A | 24757-70-8 | |
| 2'-Deoxy-α-Adenosine | 3413-66-9 | |
| 1-(2,3-DIhydro-1,4-benzodioxin-6-yl)-3-(3-phenyl-1-pyrrolidinyl)-1-propanone hydrochloride | 33025-33-1 | |
| Ethyl 3-({3-amino-4-[(3,5-dimethoxy-2,4,6-triazine)(methyl)amino]benzoyl}pyridin-2-yl-amino)propanoate
(Dabigatran impurity) |
Not available | |
| 2-[(4-cyanophenyl)amino]-N-(4-cyanophenyl)-acetamide | 1900865-84-0 | |
| Ethyl 3-[(4-{[N-(4-cyanophenyl)glycyl](methyl)amino}3- aminobenzoyl)pyridin-2-ylamino]propanoate | 1648817-93-9 | |
| Ethyl 2-[(4-carbamimidoyl-phenylamino)-methyl]-1-methyl-1H-benzoimidazole-5-carboxylate | 1408238-41-4 | |
| 2-[(4-cyanophenyl)amino]acetic acid | 42288-26-6 | |
| ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate | 212322-56-0 | |
| Boc-D-His(Trt)-OH | 393568-74-6 | |
| Fmoc-AEEA-OH | 166108-71-0 | |
| Boc-AEEA-OH | 108466-89-3 | |
| H-AEEA-OH | 134978-97-5 | |
| Boc-AEEA-AEEA | 1069067-08-8 | |
| 2-[2-[(Triphenylmethyl)amino]ethoxy]ethanol | 202873-24-3 | |
| Palbociclib Imp-A | 1082876-26-3 | |
| R-3-amino-4-(2,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4] triazolo [4,3-a] pyrazin-7 (8H)-yl)butan-1-one | 1334244-28-8 | |
| R-3-amino-4-(2,5-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4] triazolo [4,3-a] pyrazin-7 (8H)-yl)butan-1-one | 486460-31-5 | |
| R-3-amino-4-(3,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4] triazolo [4,3-a] pyrazin-7 (8H)-yl)butan-1-one | 486459-88-5 | |
| R-3-amino-4-(2,3-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4] triazolo [4,3-a] pyrazin-7 (8H)-yl)butan-1-one | NA | |
| R-3-amino-4-(2,3,4-trifluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4] triazolo [4,3-a] pyrazin-7 (8H)-yl)butan-1-one | NA | |
| R-3-amino-4-(3,4,5-trifluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4] triazolo [4,3-a] pyrazin-7 (8H)-yl)butan-1-one | NA | |
| R-3-amino-4-(2,3,5-trifluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4] triazolo [4,3-a] pyrazin-7 (8H)-yl)butan-1-one | 945261-49-4 | |
| R-3-amino-4-(2,3,6-trifluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4] triazolo [4,3-a] pyrazin-7 (8H)-yl)butan-1-one | 945261-50-7 | |
| methyl 4-methoxy-5-((3-morpholinopropoxy)methyl)-2-nitrobenzoate | 214472-37-4 | |
| methyl 2-amino-4-methoxy-5-((3-morpholinopropoxy)methyl)benzoate | 214472-41-0 | |
| Palbociclib Imp-B | 571189-64-5 | |
| Palbociclib Imp-C | 2624141-94-0 | |
| Palbociclib Imp-D | 775288-71-6 | |
| Palbociclib Imp-E | 851067-56-6(free base) | |
| Palbociclib Imp-G | 1651214-74-2 | |
| Sorafenib Impurity A | 284462-37-9 | |
| Sorafenib Impurity B | 2004659-84-9 | |
| Sorafenib Impurity C | 320-51-4 | |
| Sorafenib Impurity H BP | 1431697-81-2 | |
| 2-aminothiophenol | 137-07-5 | |
| Ondasetron EP Impurity A | 153139-56-1 |
|
| Ondasetron EP Impurity B | 1076198-52-1 | |
| Ondasetron EP Impurity C | 27387-31-1 | |
| Ondasetron EP Impurity D | 99614-64-9 | |
| Ondasetron EP Impurity E | 288-32-4 | |
| Ondasetron 2-Methyl imidazole EP Impurity F | 693-98-1 | |
| Ondasetron EP Impurity G | 99614-03-6 | |
| Ondasetron EP Impurity H | 99614-14-9 | |
| 2-nitro-1,3-propanediol | 1794-90-7 | |
| 2-bromo-2-nitropropane-1,3-diol | 52-51-7 | |
| Tris(hydroxymethyl)nitromethane | 126-11-4 | |
| (S)-5,7-difluorochroman-4-ol | 942195-91-7 | |
| 5,7-Difluoro-3,4-dihydro-2H-1-benzopyran-4-ol | 917248-51-2 | |
| (4R)-5,7-Difluoro-3,4-dihydro-2H-1-benzopyran-4-ol | 1270294-05-7 | |
| R-(-)-2-aminobutanamide hydrochloride (RABAM HCl) | [103765-03-3] | |
| S-2-aminobutyramide hydrochloride (SABAM) | [7682-20-4] | |
| (S)-4-propyldihydrofuran-2(3H)-one | 63095-60-3 | |
| Clemastine Impurity C | 59767-24-7 | |
| Clemastine Impurity D | 67004-64-2 | |
| Clemastine Fumarate | 14976-57-9 | |
| Clemastine Impurity A | 108825-05-4 | |
| Clemastine Impurity B | 1352549-49-5 | |
| Benazepril Impurity B | 88372-39-8 | |
| 5-amino-N-(4-(bis(5-amino-2-methylphenyl)methyl)phenyl)-2-methylbenzenesulfonamide
|
1226500-00-0 | |
| Pazopanib trimer | 1226500-01-1 | |
| 2,2-Dimethyl-5-nitro-1,3-dioxane | 4064-87-3 | |
| 2,2-Dimethyl-5-nitro-1,3-dioxane-5-methanol | 4728-14-7 | |
| 2,2-Dimethyl-1,3-dioxan-5-amine | 40137-24-4 | |
| 2-(Methylamino)-1,3-propanediol | 77697-86-0 | |
| 1,3-Propanediol, 2-(methylamino)-, hydrochloride | 785816-82-2 | |
| Benzonatate | 104-31-4 | |
| 2-(2-(2-Methoxyethoxy)ethoxy)ethanol | 112-35-6 | |
| 2,5,8,11,14,17,20,23,26-Nonaoxaoctacosan-28-ol | 6048-68-6 | |
| 4-(Butylamino)benzoic acid | 4740-24-3 | |
| Ethyl 4-(butylamino)benzoate | 94-32-6 | |
| 3,6,9,12,15,18,21,24-Octaoxahexacosane-1,26-diol | 3386-18-3 | |
| Methyl 4-aminobenzoate | 619-45-4 | |
| Butyl 4-aminobenzoate | 94-25-7 | |
| 2,5,8,11,14,17,20,23,26-Nonaoxaoctacosan-28-ol | 6048-68-6 | |
| 2,5,8,11,14,17,20,23-Octaoxapentacosan-25-ol | 25990-96-9 | |
| O-Methylheptaethylene Glycol | 4437-01-8 | |
| 2,5,8,11,14,17-Hexaoxanonadecan-19-ol | 23601-40-3 | |
| Pentaethylene Glycol Monomethyl Ether | 23778-52-1 | |
| 2,5,8,11-Tetraoxatridecan-13-ol | 23783-42-8 | |
| 2,5,8,11,14,17,20,23,26,29-Decaoxahentriacontan-31-ol | 27425-92-9 | |
| 4-NITROBENZOIC ACID | 62-23-7 | |
| BUTYRALDEHYDE | 123-72-8 | |
| 1-bromobutane | 109-65-9 | |
| Benzonatate dimer | Not available | |
| Debutyl benzonatate | 103042-95-1 | |
| Benzonatate Impurity-A | 105520-53-4 | |
| Psedobenzonatate (Oligomer-3) | 1430060-86-8 | |
| Butyl 4-(butylamino)benzoate | 1029292-13-4 | |
| Benzoic acid, 4-(butylamino)-, methyl ester | 71839-12-8 | |
| 4-Aminobenzoic acid | 150-13-0 | |
| Benzonatate oligomer-11 | 104399-42-0 | |
| Benzonatate oligomer-10 | Not available | |
| Benzonatate oligomer-08 | 124117-03-9 | |
| Benzonatate oligomer-07 | 1430060-90-4 | |
| Benzonatate oligomer-06 | 1430060-89-1 | |
| Benzonatate oligomer-05 | 1430060-88-0 | |
| Benzonatate oligomer-04 | 1430060-87-9 | |
| Ethyl p-aminobenzoate | 94-09-7 | |
| Atorvastatin Imp. A | 433289-84-0 | |
| Atorvastatin Imp. B | 842103-12-2 | |
| Atorvastatin Imp. H | 125995-03-1 | |
| Atorvastatin Imp. 1 | 906552-18-9 | |
| Atorvastatin Imp. 2 | 873950-17-5 | |
| Atorvastatin Imp. 3 | 873950-18-6 | |
| Atorvastatin Imp. 4 | 873950-19-7 | |
| Tris(2,4-di-tert-butylphenyl)phosphate | 95906-11-9 | |
| Imp.6 of Rivaroxaban amino intermediate | 1265682-11-8 | |
| Olmesartan Dimer Ester Impurity | 1040250-19-8 | |
| Deshydroxy Impurity- 4-(1-Cyc1ohexyl-2-(dimethylamino)ethy1)phenol | 1346605-18-2 | |
| Carbamazepine Methyl carbamate Impurity | 105926-34-9 | |
| methylacetamide Diphenylamine | 1007115-91-4 | |
| Torsemide Impurity A | 72810-61-8 | |
| Torsemide Impurity C | 58155-35-4 | |
| Rabeprazole sulphone | 117976-47-3 | |
| Metoprolol succinate Impurity A | 109632-08-8 | |
| Voriconazole imp. B | 182369-73-9 | |
| Voriconazole imp. D | 137234-63-0 | |
| 2-Desmethyl-4-methyl Tolvaptan | 1580889-25-3 | |
| Tolvaptan 3-methyl impurity | 1580889-27-5 | |
| 5-Dehydrotolvaptan | 137973-76-3 | |
| Deschlorotolvaptan | 1432725-23-9 | |
| 7-Chloro-1,2,3,4-tetrahydro-1-(2-methyl-4-nitrobenzoyl)-5H-1-benzazepin-5-one | 137982-91-3 | |
| 7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one | 160129-45-3 | |
| 7-Chloro-1,2,3,4-tetrahydro-1-[(4-methylphenyl)sulfonyl]-5H-1-benzazepin-5-one | 193686-76-9 | |
| 4-(3-Chlorophenyl)-4-oxo-2-butenoic Acid | 191015-04-0 | |
| 1,2,3,4-Tetrahydro-1-(4-amino-2-methylbenzoyl)-7-chloro-5H-1-benzazepin-5-one | 137977-97-0 | |
| (R)-(+)-Tolvaptan | 331947-66-1 | |
| (S)-(-)-Tolvaptan | 331947-44-5 | |
| Benzamide, N-[4-[(7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl]phenyl]-2-methyl- | 150683-27-5 | |
| 2-methyl-2-propanyl (2,2-dimethyl-l,3-dioxan-5- yl)methyl carbamate | 2286266-85-9 | |
| 1,3-Dioxan-5-one, 2,2-dimethyl- | 74181-34-3 | |
| Carbamic acid, [5-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-5-yl]-, phenylmethyl ester | 420107-80-8 | |
| 1,1-Dimethylethyl N-(2,2-dimethyl-1,3-dioxan-5-yl)carbamate | 1780649-07-1 | |
| Phenylmethyl N-(2,2-dimethyl-1,3-dioxan-5-yl)carbamate | 1029627-71-1 | |
| Benzyl (1,3-dihydroxypropan-2-yl)carbamate | 71811-26-2 | |
| 1-methyl-3-(methyl amino)-2,5-dihydro-1H-pyrrole-2,5-dione | 457959-68-1 | |
| Isonaringin | 14259-46-2 | |
| 2-Methyl-4-nitrobenzoic acid | 1975-51-5 | |
| N-nitroso diethanolamine | 1116-54-7 | |
| Carbamic acid, N-[2-[bis(4-methoxyphenyl)phenylmethoxy]-1-(hydroxymethyl)ethyl]-N-methyl-, 9H-fluoren-9-ylmethyl ester (ACI) | 1801414-92-5 | |
| Phenylmethyl N-[2-(2-hydroxyethoxy)ethyl]carbamate | 145881-74-9 | |
| (±)-Hydroxyzine | 68-88-2 | |
| R-Hydroxyzine | 189298-46-2 | |
| (S)-Hydroxyzine | 189298-45-1 | |
| Hydroxyzine hydrochloride | 2192-20-3 | |
| Hydroxyzine monohydrochloride | 1244-76-4 | |
| Lacosamide EP Impurity A (S-ISOMER) | 175481-37-5 | |
| Lacosamide EP Impurity B | 1822463-67-1 | |
| Lacosamide EP Impurity C | 2742962-60-1 | |
| Lacosamide EP Impurity D | 262845-82-9 | |
| Lacosamide EP Impurity E | 175481-39-7 | |
| Lacosamide EP Impurity F | 171623-02-2 | |
| Lacosamide EP Impurity G | 588-46-5 | |
| Lacosamide EP Impurity H | 1375090-19-9 | |
| Lacosamide EP Impurity I | 2295925-90-3 | |
| Cetirizine EP impurity A (CBHP) | 303-26-4,1031-92-1 (HCl salt) | |
| Cetirizine EP impurity B (Cetirizine acetic acid) | 113740-61-7, 1000690-91-4 (HCl salt) | |
| Cetirizine EP impurity C (2-Chlorocetirizine) | 83881-59-8, 2702511-37-1 (HCl salt) | |
| Cetirizine EP impurity D (Cetirizine dimer) | 346451-15-8, 856841-95-7 (HCl salt) | |
| Cetirizine EP impurity E | 682323-77-9, 83881-56-5 (HCl salt) | |
| Cetirizine EP impurity F (Deschlorocetirizine) | 83881-53-2, 83881-54-3 (HCl salt) | |
| Cetirizine EP impurity G (Cetirizine ethanol) | 109806-71-5, 164726-80-1 (HCl salt) | |
| (S)-Cetirizine Dihydrochloride | 163837-48-7 | |
| Cetirizine n-oxide | 1076199-80-8 | |
| Cetirizine amide | 83881-37-2, 200707-85-3 (HCl salt) | |
| Cetirizine methyl ester | 83881-46-3 | |
| 3-Chlorocetirizine | 1232460-31-9, 1232460-29-5 (HCl salt) | |
| 4-CBH | 119-56-2 | |
| 4-Chlorobenzophenone | 134-85-0 | |
| (3S)-3-(carbamoylmethyl)-5-methylhexanoic acid (pregabalin impurity) | 181289-34-9 | |
| Desbromo bedaquiline | 654654-19-0 | |
| 2-Thiophene carboxylic acid | 527-72-0 | |
| 3-Chlorothiophene-2-carboxylic acid | 59337-89-2 | |
| 4-Chlorothiophene-2-carboxylic acid | 59614-95-8 | |
| 4,5-dichlorothiophene-2-carboxylic acid | 31166-29-7 | |
| 2-Chlorothiophene-3-carboxylic acid | 53935-71-0 | |
| 2-Chlorothiophene | 96-43-5 | |
| (S)-2-(3-Chloro-2-hydroxypropyl)isoindoline-1,3-dione | 148857-42-5 | |
| (R)-2-(Oxiran-2ylmethyl)isoindoline-1,3-dione | 181140-34-1 | |
| 3-[(1R,2S,3S,4S)-2,3-Dihydroxy-4-(2-hydroxyethoxy)cyclopentyl]-3,6-dihydro-5-(propylthio)-7H-1,2,3-triazolo[4,5-d]pyrimidin-7-one (Ticagrelor impurity) | 1445580-43-7 | View Details |
| (1S,2R)-rel-2-(4-chloro-3-fluorophenyl)cyclopropan-1-amine | 1808068-84-9 | View Details |
| (1R,2R)-2- (3,4-difluorophenyl)cyclopropanecarboxylic acid | 220352-36-3 | |
| Deferasirox impurity B | 1218-69-5 | |
| Deferasirox impurity E | 201530-79-2 | |
| Ipratropium bromide impurity A | 58005-18-8 | |
| Ipratropium bromide impurity D | 492-38-6 | |
| Ipratropium bromide impurity E | 22235-81-0 | |
| Ipratropium bromide impurity F | 17812-46-3 | |
| Brinzolamide related compound B | 404034-55-5(free base) | |
| Moxonidine impurity A | 352457-35-3 | |
| Moxonidine impurity B | 75439-01-9 | |
| Escitalopram olefinic impurity | 1370643-22-3 | |
| Citalopram R-Isomer | 219861-53-7 | |
| Escitalopram Impurity-M | 440121-09-5 | |
| Escitalopram alkene dimer impurity | 1370643-27-8 | |
| Ezetimibe ketone impurity | 191330-56-0 | |
| Ezetimibe impurity-A | 1593543-07-7 | |
| Ezetimibe impurity-B | 1368310-60-4 | |
| Ezetimibe impurity-C | 189028-93-1 | |
| Ezetimibe impurity-D | 191330-56-0 | |
| Ezetimibe m-fluoro analog | 1700622-06-5 | |
| Ezetimibe desfluoro impurity | 302781-98-2 | |
| Itraconazole impurity-A | 252964-68-4 | |
| Itraconazole impurity-D | 89848-49-7 | |
| Itraconazole impurity-C | 74855-91-7 | |
| Itraconazole impurity-F | 89848-51-1 | |
| Itraconazole impurity-G | Not available | |
| Tafamidis Meglumine | 951395-08-7 | |
| Paricalcitrol Z-Isomer | 1884139-61-0 | |
| Propofol impurity-J | 1988-11-0 | |
| Voriconazole chloro compound | 188416-35-5 | |
| Voriconazole Impurity-A | 86404-63-9 | |
| Voriconazole reference standard | 137234-62-9 | |
| Labetalol keto compound | 96441-14-4; 85665-85-6 (free base) | |
| 5- chloro acetyl salicylamide | 33254-88-5 | |
| Labetalol impurity-A | 1391051-99-2 | |
| Labetalol nitroso impurity | 2820170-74-7 | |
| Aripiprazole Impurity-A | 22246-18-0 | |
| Aripiprazole Impurity-B | 119532-26-2; 41202-77-1 (free base) | |
| Aripiprazole Impurity-E | 129722-25-4; 1428331-96-7 (hydrate); 2389989-55-1 (2 HCl salt) | |
| Aripiprazole Impurity-F | 573691-09-5 | |
| Lacosamide S-Isomer | 175481-37-5 | |
| Lacosamide Impurity-E | 175481-39-7 | |
| Lacosamide Impurity-F | 171623-02-2 | |
| Lacosamide Impurity-G | 588-46-5 | |
| Lacosamide Impurity-K | 86921-49-5 | |
| Lacosamide Impurity-I | 2295925-90-3 | |
| Linezolid impurity-G | 391068-25-9/333753-69-8(free base) | |
| Linezolid descarbonyl | 333753-67-6 | |
| Linezolid impurity-A | 212325-40-1 | |
| Linezolid impurity-B | 216868-57-4 | |
| Linezolid R-Isomer | 872992-20-6 | |
| Linezolid related compound-C | 168828-90-8 | |
| Donepezil impurity-D | 4803-57-0 | |
| Donepezil related compound-A | 145546-80-1 | |
| Hydroxy donepezil | 2097683-67-3 | |
| Donepezil desbenzyl impurity | 120013-39-0 | |
| Donepezil impurity-E | 231283-82-2 757173-38-9 (free base) | |
| Ramipril impurity-A | 108313-11-7 | |
| Ramipril impurity-B | 295328-72-2 | |
| Ramipril impurity-D | 108731-95-9 | |
| Ramipril impurity-E | 87269-97-4 | |
| Enrofloxacin Impurity-A | 86393-33-1 | |
| Lurasidone cis exo impurity | 139563-25-0 | |
| Lurasidone S,S Endo impurity | 1318074-27-9 | |
| Lurasidone R,R Endo impurity | 1318074-25-7 | |
| Ciprofloxacin N-nitroso impurity | 864443-44-7 | |
| Ciprofloxacin impurity-F | 226903-07-7 | |
| Ciprofloxacin methyl ester | 107884-23-1 | |
| Ciprofloxacin impurity-E | 105394-83-0 | |
| Ciprofloxacin impurity-C | 528851-31-2; 103222-12-4 (free base) | |
| Rivaroxaban R-isomer | 865479-71-6 | |
| Rivaroxaban deschloro impurity | 1415566-28-7 | |
| Levofloxacin N-desmethyl impurity | 117707-40-1 | |
| Levofloxacin D-enantiomer | 100986-86-5 | |
| Levofloxacin nitroso impurity | 1152314-62-9 | |
| Desfluoro levofloxacin | 117620-85-6 | |
| Levofloxacin N-Oxide | 117678-38-3 | |
| Dorzolamide Impurity-A | 122028-36-8 120279-95-0 (free base) | |
| Enalapril malate impurity-A | 76420-74-1 | |
| Enalapril malate impurity-B | 82717-96-2 | |
| Enalapril malate impurity-C | 76420-72-9 | |
| Enalapril malate impurity-D | 115729-52-7 | |
| Enalapril malate impurity-G | 460720-14-3 | |
| Enalapril malate impurity-H | 2055735-10-7 | |
| Sotolol n-nitroso | 134720-07-3 | |
| Sotolol impurity-C | 83922-54-7 | |
| Mitrazapine impurity-F | 191546-97-1 | |
| Mitrazapine des hydroxy | 191546-94-8 | |
| Mitrazapine impurity-A | 155172-12-6 | |
| Olanzapine Impurity-A | 138564-59-7 | |
| Olanzapine chloromethyl impurity | 719300-59-1 | |
| Olanzapine impurity-B | 221176-49-4 | |
| Sacubitril 2R, 4S isomer | 761373-05-1 | |
| Sacubitril 2S, 4S isomer | 149709-63-7 | |
| Ivabradine R-isomer | 148849-68-7 | |
| Ivabradine hydroxyl impurity | 304464-98-0 | |
| Posaconazole intermediate-A | 149809-43-8 |
|
| Posaconazole benzyl impurity | 170985-86-1 | |
| Posaconazole impurity-C | 357189-96-9 | |
| Dabigatran pentylchloroformate impurity | 1580491-16-2 | |
| Dabigatran ethyl butyl isomer | 1610758-20-7 | |
| Salmeterol impurity-C | 94749-11-8 | |
| Levetiracetam related compound-B | 7682-20-4 | |
| Levetiracetam impurity-C | 142-08-5 | |
| Levetiracetam R,R-Isomer | 103765-01-1/td> | |
| Salbutamol sulfate impurity-B | 96948-64-0 112337-52-7 (HCl salt) | |
| Salbutamol sulfate impurity-H | 132183-64-3 | |
| Salbutamol sulfate impurity-M | 18910-70-8 27566-30-9(HCl Salt) | |
| Palonosetron RS Isomer | 135755-51-0 | |
| Palonosetron RR Isomer | 135729-75-8 | |
| Moxifloxacin RR Isomer | 1394029-14-1 | |
| Entacapone methoxy | 857629-78-8 | |
| 3,4-Dihydroxy-5-nitrobenzaldehyde | 116313-85-0 | |
| Entacapone Z-Isomer | 145195-63-7 | |
| Paliperidone stearate impurity | 1172995-13-9 | |
| Paliperidone myristate impurity | 1172995-11-7 | |
| Ofloxacin impurity-B | 123155-82-8 | |
| Ofloxacin Impurity-F | 104721-52-0 | |
| N-Methyl-2-nitroaniline | 612-28-2 | |
| Methyl 4-(methylamino)benzoate | 18358-63-9 | |
| 3-Bromo-5,6,7,8-tetrahydro-1,6-naphthyridine hydrochloride | 1159010-96-4 | |
| 3-BroMo-5,6,7,8-tetrahydro-1,6-naphthyridine dihydrochloride | 1187932-53-1 | |
| 3-BROMO-5,6,7,8-TETRAHYDRO-1,6-NAPHTHYRIDINE | 625100-00-7 | |
| 4-Fluoro-3-nitrobenzoic acid | 453-71-4 | |
| Methyl 4-fluoro-3-nitrobenzoate | 329-59-9 | |
| 2-Chloro-4,6-dimethoxy-1,3,5-triazine | 3140-73-6 | |
| Ethyl 3-(4-(methylamino)-3-nitro-N-(pyridin-2-yl)benzamido)propanoate | 429659-01-8 | |
| 2-AMINO-4,6-DIMETHOXY-1,3,5-TRIAZINE | 16370-63-1 |
|
| 4,6-Dimethoxy-N-methyl-1,3,5-triazin-2-amine | 30357-98-3 | |
| Ethyl 2-bromobutanoate | 533-68-6 | |
| Diphenylphosphine oxide | 4559-70-0 | |
| Benzoic acid, 4-(methylamino)-3-nitro-, methyl ester | 36242-50-9 | |
| 1-Methyl-3,5-dinitro-1H-pyridin-2-one | 14150-94-8 | |
| 1-Benzylpiperidin-4-one | 3612-20-2 | |
| 1,1-Dimethylethyl 3-bromo-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate | 1184950-48-8 | |
| (3-Bromo-7,8-dihydro-1,6-naphthyridin-6(5H)-yl)(4-fluorophenyl)methanone | 1384873-49-7 | |
| (3-Bromo-7,8-dihydro-1,6-naphthyridin-6(5H)-yl)cyclopropylmethanone | 1629240-44-3 | |
20. |
7,8-Dihydro-3-(phenylmethoxy)-1,6-naphthyridin-6(5H)-yl]phenylmethanone | 1616293-39-0 |
| N-[3-Amino-4-(methylamino)benzoyl]-N-2-pyridinyl-β-alanine ethyl ester | 212322-56-0 | |
| (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine | 220352-38-5 | |
| Acetic acid, 2-[[(3aR,4S,6R,6aS)-6-[7-chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-, ethyl ester | 1402150-01-9 | |
| 6-Amino-5-nitropyrimidine-2,4(1H,3H)-dione | 3346-22-3 | |
| 2,6-Dichloro-4,5-pyrimidinediamine | 130838-36-7 | |
| 5,7-Dichloro-3H-1,2,3-triazolo[4,5-d]pyrimidine | 500338-80-7 | |
| Vibegron | 1190389-15-1 | |
| N-Nitroso vibegron | Not available | |
| Cyclopropanol | 16545-68-9 | |
| Cyclopropyl bromide | 4333-56-6 | |
| 4-(Methylamino)benzoic acid | 10541-83-0 | |
| 4-Amino-2,6-dichloropyrimidine | 10132-07-7 | |
| 2,3-Dihydro-1H-inden-1-one | 83-33-0 | |
| 1-Thiophen-2-yl-ethanone | 88-15-3 | |
| 2-Cyclopropoxyethyl 4-methylbenzenesulfonate | 862728-59-4 | |
| 4-(5-Bromo-2-chlorobenzyl)phenol | 864070-18-8 | |
| N-METHYLANILINE | 100-61-8 | |
| 2-NITROANILINE | 88-74-4 | |
| SERTRALINE ENANTIOMER | 79617-98-4 | |
| 4-Bromo-1-chloro-2-[[4-[2-(cyclopropyloxy)ethoxy]phenyl]methyl]benzene | 1118567-45-5 | |
| 2-(Cyclopropyloxy)ethanol | 20117-44-6 | |
| (2-Bromoethoxy)cyclopropane | 1207294-80-1 | |
| 2,3-Dihydroxybenzoic acid | 303-38-8 | |
| Amlodipine EP Impurity A | 88150-62-3 | |
| Amlodipine EP Impurity B | 721958-72-1 | |
| Amlodipine EP Impurity D / Amlodipine related compound A | 2138811-33-1 | |
| Amlodipine EP Impurity E | 140171-65-9 400024-12-6 (maleate Salt) | |
| Amlodipine EP Impurity F | 140171-66-0 400024-11-5 (maleate salt) | |
| Amlodipine EP Impurity G | 43067-01-2 | |
| Amlodipine EP Impurity H | 318465-73-5 | |
| Hydroxyethyl Phthalyl Amlodipine impurity | Not available | |
| N-nitrosoamlodipine impurity | Not available | |
| Buspirone EP Impurity C | 257877-45-5 | |
| (2S,3R)-2,3-dihydro-3-hydroxy-2-94-methoxyphenyl0benzo[b][1,4]thiazepine-4(5H)-one.(Trans Lactam-DILTIAZEM)(S,R-isomer) | 132830-16-1 | |
| (2R,3S)-2,3-dihydro-3-hydroxy-2-94-methoxyphenyl0benzo[b][1,4]thiazepine-4(5H)-one.(Trans Lactam DILTIAZEM) (R,S-isomer) | 132830-17-2 | |
| (2R,3R)-2,3-dihydro-3-hydroxy-2-94-methoxyphenyl0benzo[b][1,4]thiazepine-4(5H)-one.(L-Lactam DILTIAZEM)(R,R-isomer) | 42399-51-9 | |
| Perindopril EP Impurity A | 80875-98-5 | |
| Perindopril EP Impurity B | 95153-31-4 | |
| Perindopril EP Impurity C | 129970-99-6 | |
| Perindopril EP Impurity D | 130061-28-8 | |
| Perindopril EP Impurity E | 1356837-89-2; 2771193-11-2 (t-Butylamine salt) | |
| Perindopril EP Impurity F | 129970-98-5 | |
| Perindopril EP Impurity H | 353777-64-7 | |
| Perindopril EP Impurity K | 2165676-00-4 | |
| 4-Bromo-6-(1-bromoethyl)-5-fluoropyrimidine | 1307315-02-1 | |
| 4-Chloro-6-(1,1-dibromoethyl)-5-fluoropyrimidine | 908352-44-3 | |
| PINAVERIUM PIN-V IMPURITY | 1235355-01-7 | |
| Diacerein EP Impurity A | 518-82-1 | |
| Diacerein EP Impurity B | 481-72-1 | |
| Diacerein EP Impurity C | 478-43-3 | |
| Diacerein EP Impurity D | 875535-35-6 | |
| Diacerein EP Impurity E | 875535-36-7 | |
| Diacerein EP Impurity F | 13928-72-8 | |
| Diacerein EP Impurity G | 25395-11-3 | |
| Diacerein EP Impurity H | 64951-96-8 | |
| Desfluoro Rosuvastatin Calcium Salt | 847849-66-5 | |
| Iopromide Related compound A | 154361-51-0 | |
| Iopromide Related compound B | 76350-28-2 | |
| (R)-diethyl 2-((tert-butoxycarbonyl)amino)pentanedioate | 93720-76-4 | |
| N2,N2,6-trimethyl-1,3,5-triazine-2,4-diamine | 21320-31-0 | |
| 4-Chloro-1-(2-fluorophenyl)butan-1-one | 2823-19-0 | |
| (2S,3aR,7aR)-Octahydro-indole-2carboxylic acid (SRR) | 145513-90-2 | |
| (2R,3aR,7aR)-Octahydro-indole-2carboxylic acid (RRR) | 108507-42-2 | |
| Posaconazole Trans isomer | 159811-30-0 | |
| Mirabegron Impurity-D | 2489747-26-2 | |
| Dehydro lercanidipine | 887769-34-8 | |
| Dehydro manidipine | 104305-93-3 | |
| Clevidipine butyrate impurity iv | 188649-48-1 | |
| Nifedipine EP impurity A | 67035-22-7 | |
| Felodipine EP Impurity A | 96382-71-7 | |
| Nitrendipine impurity A | 89267-41-4 | |
| Nilvadipine Impurity F | 99935-62-3 | |
| Lacidipine Imp. B (BP) | 130996-24-6 | |
| Isradipine impurity D | 116169-18-7 | |
| Nimodipine impurity A | 85677-93-6 | |
| Nisoldipine USP RC D | 103026-83-1 | |
| 5-(Chloromethyl)-1,3-benzodioxole | 20850-43-5 | |
| Benzo[d][1,3]dioxole | 274-09-9 | |
| Benzo[d][1,3]dioxol-5-ylmethanol | 495-76-1 | |
| Verapamil EP Impurity A | 141991-88-0 63434-11-7 (HCl salt) | |
| Verapamil EP Impurity B | 3490-06-0 13078-76-7 (HCl salt) | |
| Verapamil EP Impurity C | 3490-05-9 51012-67-0 (HCl salt) | |
| Verapamil EP Impurity D | 36770-74-8 36770-75-9 (HCl salt) | |
| Verapamil EP Impurity E | 93-03-8 | |
| Verapamil EP Impurity F | 34245-14-2 67775-97-7 (HCl salt) | |
| Verapamil EP Impurity G | 120-14-9 | |
| Verapamil EP Impurity H | 67018-83-1 190850-49-8 (HCl salt) | |
| Verapamil EP Impurity I | 2893-91-6 1794-55-4(HCl salt) | |
| Verapamil EP Impurity J | 67018-85-3 67812-42-4 (HCl salt) | |
| Verapamil EP Impurity K | 20850-49-1 | |
| Verapamil EP Impurity L | 14046-55-0 | |
| Verapamil EP Impurity M | 141991-89-1 190850-50-1(HCl salt) | |
| Verapamil EP Impurity N | 2086274-75-9 2726492-31-3 (HCl salt) | |
| Verapamil EP Impurity O | 959011-16-6 2732309-77-0 (HCl salt) | |
| Verapamil EP Impurity P | 2086275-13-8 | |
| Nebivolol Related Compound A | Not available | |
| Nebivolol Related Compound B | Not available | |
| Nebivolol Related Compound C | 876514-31-7 | |
| Nebivolol Related Compound D | 793669-26-8 | |
| Nebivolol Related Compound E | Not available | |
| Nebivolol Stereoisomer mixture | Not available | |
| Nebivolol EP impurity A | 118457-16-2 | |
| Nebivolol EP impurity B | 99200-09-6 | |
| Nebivolol EP impurity C | Not available | |
| Nebivolol EP impurity D | 119365-22-9 | |
| Dronedarone Hydroxy Impurity | Not available | |
| Ethyl 4-iodo-3-nitrobenzoate | 57362-77-3 | |
| Benzoic acid, 4-iodo-3-nitro-, methyl ester | 89976-27-2 | |
| 4-Iodo-3-nitrobenzoic acid | 35674-27-2 | |
| 3-Amino-4-iodobenzoic acid | 51411-81-5 | |
| Benzoic acid, 3-amino-4-iodo-, methyl ester | 412947-54-7 | |
| Benzoic acid, 3-amino-4-iodo-, ethyl ester | 1261569-51-0 | |
| 5-Methyl-3-nitro-2-pyridinamine | 7598-26-7 | |
| 5-Methyl-2,3-pyridinediamine | 24638-29-7 | |
| (3S,5S)-Atorvastatin Acetonide tert-Butyl Ester | 472967-95-6 | |
| Finerenone | 1050477-31-0 | |
| Finerenone acid impurity | 2640506-74-5 | |
| 1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-, 2-cyanoethyl ester | 2640574-73-6 | |
| Finerenone ethyl ester impurity | 2764833-09-0 | |
| Dehydro Finerenone | 2084136-51-4 | |
| (Rac)-Finerenone | 1050477-27-4 | |
| Benzonitrile, 4-[(4-amino-2-ethoxy-5-methyl-3-pyridinyl)hydroxymethyl]-3-methoxy- | 2569527-40-6 | |
| 3-Oxobutanamide | 5977-14-0 | |
| 1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-, 2-propen-1-yl ester | 2968510-26-9 | |
| Finerenone enantiomer (R-Finerenone) | 1050477-30-9 | |
| Propanamide, N-[3-[(4-cyano-2-methoxyphenyl)hydroxymethyl]-2-ethoxy-5-methyl-4-pyridinyl]-2,2-dimethyl- | 2569527-39-3 | |
| Finerenone aldehyde impurity | 2764833-08-9 | |
| 4-Formyl-3-methoxybenzonitrile | 21962-45-8 | |
| N-(2-Ethoxy-5-methyl-4-pyridinyl)-2,2-dimethylpropanamide | 2569527-38-2 | |
| 2-Cyanoethyl 3-Oxobutyrate | 65193-87-5 | |
| 2,2,6-Trimethyl-4H-1,3-dioxin-4-one | 5394-63-8 | |
| 3-Methoxy-4-methylbenzoic acid | 7151-68-0 | |
| 2-Chloro-5-methylpyridine | 18368-64-4 | |
| 3-Hydroxypropionitrile | 109-78-4 | |
| Methyl 3-oxobutanoate | 105-45-3 | |
| Methyl 2-ethoxy-1H-benzo[d]imidazole-7-carboxylate | 150058-27-8 | |
| Bexagliflozin | 1118567-05-7 | |
| Methoxy bexagliflozin | 1118567-46-6 | |
| Bexagliflozin l-Proline complex | 1118567-48-8 | |
| Tetraacetyl bexagliflozin | ||
| Tetraacetyl bexagliflozin | 2251691-23-1 | |
| 1-Chloro-2-[[4-[2-(cyclopropyloxy)ethoxy]phenyl]methyl]-4-iodobenzene | 1400980-44-0 | |
| Bexagliflozin anomer | 2023012-48-6 | |
| (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-hydroxyphenyl)methyl]phenyl]-D-glucitol | 864070-37-1 | |
| α-D-Glucopyranose, 1-C-[4-chloro-3-[[4-[2-(cyclopropyloxy)ethoxy]phenyl]methyl]phenyl] | 1459754-31-4 | |
| Ethanol, 2-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]-, 1-(4-methylbenzenesulfonate) | 1118566-69-0 | |
| Ethanol, 2-[4-[(5-Iodo-2-chlorophenyl)methyl]phenoxy]-, 1-(4-methylbenzenesulfonate) | Not available | |
| 2-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]ethanol | 1118566-50-9 | |
| 2-(2-Bromoethyl)-1,3-dioxolane | 18742-02-4 | |
| 4-(5-Iodo-2-chlorobenzyl)phenol | Not available | |
| Ethyl 2-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]acetate | 1204221-60-2 | |
| (S)-(-)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole | 106092-09-5 | |
| Ethyl (S)-4-cyano-3-hydroxybutyrate | 312745-91-8 | |
| 5-(hydroxymethyl)furan-2-carbaldehyde | 67-47-0 | |
| 2-Iodo-5-methylaniline | 13194-69-9 | |
| 2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile | 214360-48-2 | |
| Edoxaban RSR isomer | 1255529-23-7 | |
| Pregabalin amide impurity | 1568181-40-7 | |
| N-Nitroso erdafitinib | Not available | |
| 2-(((3aR,4S,6S,6aS)-6-amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol | 2376278-69-0 | |
| 2-(((3aR,4R,6R,6aS)-6-amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol | 2376278-67-8 | |
| 2-(((3aS,4S,6S,6aR)-6-amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol | NA | |
| 2-(((3aS,4S,6R,6aR)-6-amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol | 2165799-36-8 | |
| 2-(((3aR,4R,6S,6aS)-6-amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol | NA | |
| 2-METHOXY-5-METHYLPYRIDINE | 13472-56-5 | |
| DIETHYL 4-OXO PYRROLIDINE-1,3-DICARBOXYLATE | 3751-82-4 | |
| N-Nitroso Hydroxyzine | 2005-04-1 | |
| N-Nitroso ambroxol | Not available | |
| 4-(Chloromethyl)-5-methyl-1,3-dioxol-2-one | 80841-78-7 | |
| 6-Bromohexylamine Hydrobromide | 14502-76-2 | |
| 6-bromohexan-1-amine | 26342-09-6 | |
| 3,4-Dihydro-2H-pyrrol-5-amine hydrochloride | 7544-75-4 | |
| N-Desmethyl-N-Nitroso doxycycline | Not available | |
| 2-(Pyridin-3-yl)acetonitrile | 6443-85-2 | |
| 2-(Pyridin-3-yl)acetamide | 3724-16-1 | |
| 3-Pyridinemethanol | 100-55-0 | |
| 3-(Chloromethyl)pyridine hydrochloride | 6959-48-4 | |
| 1-Iodo-4-methyl-2-nitrobenzene | 5326-39-6 | |
| Pimobendan impurity A | 2138391-23-6 | |
| 2-Nitrothiophenol | 4875-10-9 | |
| 2-[4-(aminomethyl)phenoxy]-N-methylethan-1-amine | 1226154-86-4 | |
| naproxen sodium impurity f (Naproxen ethyl ester) | 31220-35-6 | |
| O-Desmethylnaproxen | 52079-10-4 | |
| (αR)-6-Hydroxy-α-methyl-2-naphthaleneacetic acid | 123050-98-6 | |
| (R)-Naproxen | 23979-41-1 | |
| Naproxen ethyl analogue | 2095463-68-4 | |
| Naproxen Methyl Ester | 26159-35-3 | |
| Naproxen - Impurity H | 5111-66-0 | |
| Naproxen - Impurity I | 23981-47-7 | |
| Naproxen - Impurity J | 21388-17-0 | |
| Naproxen - Impurity K | 77301-42-9 | |
| Naproxen - Impurity L | 3900-45-6 | |
| Naproxen - Impurity M | 93-04-9 | |
| Naproxen - Impurity N | 5111-65-9 | |
| Naproxen - Impurity O | 2471-70-7 | |
| Gemfibrozil EP impurity A | 95-87-4 | |
| Gemfibrozil EP impurity B | 114413-97-7 | |
| Gemfibrozil EP impurity C | 2775292-23-2 | |
| Gemfibrozil EP impurity D | 1798429-95-4 | |
| Gemfibrozil EP impurity E | 500904-61-0 | |
| Gemfibrozil EP impurity F | 500904-64-3 | |
| Gemfibrozil EP impurity G | 3727-20-6 | |
| Gemfibrozil EP impurity H | 415724-02-6 | |
| Gemfibrozil EP impurity I | 149105-25-9 | |
| Gemfibrozil isobutyl ester | 149105-26-0 | |
| Gemfibrozil ethyl ester | 63258-18-4 | |
| Gemfibrozil isopropyl ester | 154021-24-6/td> | |
| Doxofylline/ Theophylline Impurity | 1429636-74-7 | |
| Apremilast impurity-A | 608141-44-2 | |
| Apremilast impurity-B | 15371-06-9 | |
| Apremilast impurity-E | 2487573-03-3 | |
| Ethyl 3-hydroxy-4-methoxybenzoate | 148527-38-2 | |
| ethyl 4-methoxy-3-(3-morpholin-4-ylpropoxy)benzoate | 1040264-46-7 | |
| ethyl 4-methoxy-5-(3-morpholin-4-ylpropoxy)-2-nitrobenzoate | 1040264-48-9 | |
| 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one | 199327-61-2 | |
| ethyl 2-amino-4-methoxy-5-(3-morpholin-4-ylpropoxy)benzoate | 1040264-49-0 | |
| (3,4,5-Trimethylpyridin-2-yl)methanol | 848696-99-1 | |
| Methotrexate Impurity B | 54-62-6 | |
| Methotrexate Impurity C | 2410-93-7 | |
| Methotrexate Impurity D | 2623-18-7 | |
| Methotrexate Impurity E | 70844-48-3 | |
| Methotrexate Impurity H | 67022-39-3 | |
| Methotrexate EP Impurity I | 66147-29-3 | |
| 3-[2-(4-fluorophenyl)-2-oxo-1-phenyl-ethoxy]-4-methyl-pent-2-enoic acid phenylamide (Atorvastatin impurity) | 1198087-00-1 | |
| 4-Piperidinecarboxamide, 1-[[4-[[[2-(4-hydroxy-1-piperidinyl)ethyl]methylamino]carbonyl]phenyl]methyl]- (REVEFENACIN IMPURITY) | 2975124-11-7 | |
| 1’-epi-Entecavir | 1367369-78-5 | |
| N-NITROSO-N-METHYL-4-AMINOBUTYRIC ACID (NMBA) | 61445-55-4 | |
| N-nitroso-dibutylamine (NDBA) | 924-16-3 | |
| N-nitroso-ethyl-isopropylamine (NEiPA) | 16339-04-1 | |
| N-Nitroso-diisopropylamine (NDiPA) | 601-77-4 | |
| N-nitroso-dipropylamine (NDPA) | 621-64-7 | |
| Doxazosin Impurity D | 28888-44-0 | |
| Doxazosin Impurity F | 2727065-71-4 | |
| 4-((2-borono-5-fluorobenzyl)amino)-4-oxobutanoic acid | 2113611-04-2 | |
| (4-Fluoro-2-methylphenyl)boronic acid | 139911-29-8 | |
| 2-(4-Fluoro-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | 815631-56-2 | |
| B-[2-(Bromomethyl)-4-fluorophenyl]boronic acid | 850568-01-3 | |
| 2-(2-(Bromomethyl)-4-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | 850567-57-6 | |
| B-[2-(Aminomethyl)-4-fluorophenyl]boronic acid | 850568-02-4 (HCl salt) | |
| N-(2-Hydroxyethyl)-N-phenyl nitrous amide | 25413-76-7 | |
| (S)-N-(3-(1,3-dioxoisoindolin-2-yl)-2-hydroxypropyl)-N-(4-(3-oxomorpholino)phenyl)nitrous amide (Rivaroxaban nitroso impurity-1) | Not available | |
| Vildagliptin diketo Impurity | 1789703-36-1 | |
| Vildagliptin amide | 565453-39-6 | |
| Vildagliptin EP impurity E (Vildagliptin Cyclo Imidamide) | 1789703-37-2 | |
| Vildagliptin Impurity B/Vildagliptin Dimer Impurity | 1036959-23-5 | |
| (2R)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile | 565452-98-4 | |
| (2S)-1-(2-Chloroacetyl)-2-9-pyrrolidinecarbonitrile | 207557-35-5 | |
| 1-Amino-3-adamantanol | 702-82-9 | |
| (2S)-1-(Chloroacetyl) pyrrolidine-2-carboxamide/ Impurity A | 214398-99-9 | |
| Vildagliptin Carboxylic Acid | 565453-40-9 | |
| Vildagliptin Mono keto Impurity | na | |
| Vildagliptin Carboxylic Acid Methyl Ester | 948574-56-9 | |
| Vildagliptin Nitroso Impurity 1/ Nitroso vildagliptin | na | |
| (2R)-Vildagliptin | 1036959-27-9 | |
| 2-Chloro-N-methylethanamine hydrochloride | 4535-90-4 | |
| tert-Butyl N-(2-chloroethyl)-N-methylcarbamate | 220074-38-4 | |
| (trans-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonic acid | 2124221-13-0 | |
| Potassium (trans-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonate | 2124221-14-1 | |
| (Z)-Methyl icos-11-enoate | 2390-09-2 | |
| Methyl tetracosanoate | 2442-49-1 | |
| Diltiazem Hydrochloride Impurity D as Hydrochloride | 86408-45-9 (Free base) | |
| 4-bromo-1-chloro-2-(4-(vinyloxy)benzyl)benzene (Bexagliflozin impurity) | Not available | |
| 4-(Pyridin-2-yl)benzaldehyde | 127406-56-8 | |
| (R)-2-(4-Ethyl-2,3-dioxopiperazine-1-carboxamido)-2-phenylacetic acid | 63422-71-9 | |
| 2-[[(3aS,4R,6S,6aR)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]ethanol [Ticagrelor KSM enantiomer impurity] | 2165881-71-8 | |
| 2-[[(3aS,4R,6S,6aR)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]ethanol 2,3-dihydroxysuccinate [Ticagrelor KSM enantiomer impurity] | 2376278-72-5 | |
| N-desmethyl N-nitroso Diltiazem impurity | Not available | |
| N-Nitroso desmethyl Rizatriptan impurity | Not available | |
| 2-Chloro-1-(2-fluorophenyl)-2-phenylethanone | 77294-83-8 | |
| H-DL-Gly-OBzl.HCl | 2462-31-9 | |
| Racecadotril Impurity-A | 507-09-5 | |
| Racecadotril Impurity-E | 5669-19-2 | |
| Benzyl 2-(3-(acetylthio)-2-benzylpropanamido)acetate | 81110-73-8 | |
| 7-Methyl Tryptophol | 39232-85-4 | |
| 3-(Dimethylamino) -1- methylpropyl chloride | 104614-20-2 | |
| Benzyl 2-(2-benzylprop-2-enoylamino)acetate | 87428-99-7 | |
| 1-(2-Fluorophenyl)-2-phenylethanone | 77294-82-7 | |
| Dichloro impurity[2,2-Dichloro-1,2-diphenylethanone] | 31315-51-2 | |
| (S)-1-((R)-3-Mercapto-2-methylpropanoyl)pyrrolidine-2-carboxylic acid [Epicaptopril] [Captopril EP Impurity F] | 63250-36-2 | |
| Macitentan Ethylene hydroxy Impurity | 1393813-43-8 | |
| Macitentan Pyrimidine Amine Impurity | 1393813-42-7 | |
| Rivaroxaban N-Nitroso Amide | Not available | |
| Rivaroxaban Nitroso Open-Ring Acid | Not available | |
| Azilsartan regioisomer | 1346927-36-3 | |
| Nevirapine EP Impurity D | 1391054-30-0 | |
| Ropinirole EP Impurity C | 145570-92-9 | |
| 2-Desmethyl tolvaptan | 1580889-33-3 | |
| PAL-GQPR [Pal-Gly-Gln-Pro-Arg-OH] | 221227-05-0 | |
| PAL-GHK [(S)-2-((S)-3-(1H-Imidazol-5-yl)-2-(2-palmitamidoacetamido)propanamido)-6-aminohexanoic acid | 147732-56-7 | |
| Racecadotril EP impurity-B | 76721-89-6 | |
| Racecadotril EP Impurity-C | 124735-06-4 | |
| Racecadotril EP Impurity-F | 87428-99-7 | |
| Racecadotril EP Impurity-G | 81110-69-2 | |
| 1-((2'-Cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid | 632322-61-3 | |
| Methyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate | 139481-44-0 | 2-[(Acetylthio)methyl]-3-phenylpropionic Acid | 91702-98-6 |
| 2-Benzyl-3-mercaptopropanoic acid | 81110-55-6 | |
| Benzenepropanoic acid, α,α′-[dithiobis(methylene)]bis- | 141437-87-8 | |
| Racecadotril EP Impurity-H | 141437-88-9 | |
| Racecadotril EP Impurity-D | 123658-06-0 | |
| Azilsartan Propyl analog | 147403-36-9 | |
| Azilsartan Impurity 4 [Azilsartan Methyl ester] | 147403-52-9 | |
| Ethyl-2-ethoxy-1-[[(2'-cyanobiphenyl-4-yl) methyl] benzimidazole]-7-carboxylate | 139481-41-7 | |
| Azilsartan Ethyl Impurity | 1403474-70-3 | |
| Azilsartan Impurity 8 | 1417576-01-2 | |
| Azilsartan Impurity A | 147404-76-0 | |
| Azilsartan Dimer | 1604812-35-2 | |
| Azilsartan Impurity B | 1696392-11-6 | |
| Azilsartan Impurity C | 1397836-49-5 | |
| 2-Bromobenzene-1,3-diol | 6751-75-3 | |
| 2-Chloro-3-pyridinylmethanol | 42330-59-6 | |
| 2-Bromonicotinic acid | 35905-85-2 | |
| 2,6-Dihydroxybenzoic acid | 303-07-1 | |
| 1-Isopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | 1282518-60-8 | |
| cis-4-((2-Amino-3,5-dibromobenzyl)amino)cyclohexanol [Cis-Ambroxol Hydrochloride] | 107814-37-9 | |
| Aripiprazole impurity 43 | Not available | |
| 5-(1H-1,2,4-Triazol-1-ylmethyl)-1H-indole-3-ethanamine [Rizatriptan didesmethyl impurity] | 144035-23-4 ; 1016900-28-9 (HCl salt) | |
| 3-(2-Bromoethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole [Rizatriptan bromo impurity] | 327173-96-6 | |
| 3-(2-Chloroethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole[Rizatriptan chloro impurity] | 1000673-59-5 | |
| 5-(1H-1,2,4-Triazol-1-ylmethyl)-1H-indole-3-ethanol [Rizatriptan hydroxy impurity] | 160194-39-8 | |
| N-Methyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine [N-desmethyl Rizatriptan] | 144034-84-4 | |
| N-nitroso N-desmethyl Rizatriptan | Not available | |
| 1-(4-Aminobenzyl)-1,2,4-triazole | 119192-10-8 | |
| 1-(4-Nitrobenzyl)-1H-1,2,4-triazole | 119192-09-5 | |
| 1-[(4-Hydrazinylphenyl)methyl]-1H-1,2,4-triazole hydrochloride (1:2) | 144035-22-3 [free base] |